| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH1 MYH2 MYH4 DNAH3 MYH6 MYH8 ABCA2 MYH13 ANXA1 HSPH1 DNAH2 YTHDC2 DHX9 MDN1 ABCA6 DNAH17 DDX53 ATP1B3 ATP2B1 ATP2B2 ATP2B3 ATP2B4 KIF1C HSP90AB3P | 2.49e-09 | 614 | 184 | 24 | GO:0140657 |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine phosphatase activity | 6.42e-09 | 17 | 184 | 6 | GO:0005001 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein phosphatase activity | 6.42e-09 | 17 | 184 | 6 | GO:0019198 | |
| GeneOntologyMolecularFunction | protein tyrosine phosphatase activity | TPTE2 PTPN7 PTPN14 PTPRA PTPRC PTPRD PTPRE PTPRF PTPRO PTPRS | 3.89e-08 | 103 | 184 | 10 | GO:0004725 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.42e-07 | 118 | 184 | 10 | GO:0003774 | |
| GeneOntologyMolecularFunction | phosphoprotein phosphatase activity | MYH6 MYH8 TPTE2 PTPN7 PTPN14 PTPRA PTPRC PTPRD PTPRE PTPRF PTPRO PTPRS | 1.93e-07 | 189 | 184 | 12 | GO:0004721 |
| GeneOntologyMolecularFunction | calmodulin binding | MYH1 MYH2 MYH4 MYH6 MYH8 MYH13 ESRRG CAMSAP1 ATP2B1 ATP2B2 ATP2B3 ATP2B4 UNC13A | 2.27e-07 | 230 | 184 | 13 | GO:0005516 |
| GeneOntologyMolecularFunction | microfilament motor activity | 1.22e-06 | 38 | 184 | 6 | GO:0000146 | |
| GeneOntologyMolecularFunction | estrogen response element binding | 2.19e-06 | 11 | 184 | 4 | GO:0034056 | |
| GeneOntologyMolecularFunction | P-type calcium transporter activity | 2.19e-06 | 11 | 184 | 4 | GO:0005388 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | MYH4 DNAH3 MYH8 ABCA2 DNAH2 YTHDC2 DHX9 MDN1 ABCA6 DDX53 ATP2B1 ATP2B2 ATP2B3 ATP2B4 KIF1C HSP90AB3P | 3.47e-06 | 441 | 184 | 16 | GO:0016887 |
| GeneOntologyMolecularFunction | phosphoric ester hydrolase activity | MYH6 MYH8 PDE6A TPTE2 PTPN7 PTPN14 PTPRA PTPRC PTPRD PTPRE PTPRF PTPRO PTPRS PLCE1 | 1.45e-05 | 386 | 184 | 14 | GO:0042578 |
| GeneOntologyMolecularFunction | phosphatase activity | MYH6 MYH8 TPTE2 PTPN7 PTPN14 PTPRA PTPRC PTPRD PTPRE PTPRF PTPRO PTPRS | 1.50e-05 | 287 | 184 | 12 | GO:0016791 |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 1.88e-05 | 36 | 184 | 5 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 1.88e-05 | 36 | 184 | 5 | GO:0015662 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 6.80e-05 | 109 | 184 | 7 | GO:0042626 | |
| GeneOntologyMolecularFunction | nuclear steroid receptor activity | 7.59e-05 | 25 | 184 | 4 | GO:0003707 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 8.08e-05 | 151 | 184 | 8 | GO:0015085 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | TTYH1 TRPC7 TRPC3 KCNK16 SLC39A10 PKD1L2 PKD1L3 NALCN SLC5A12 ATP1B3 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 1.09e-04 | 465 | 184 | 14 | GO:0046873 |
| GeneOntologyMolecularFunction | PDZ domain binding | 1.45e-04 | 123 | 184 | 7 | GO:0030165 | |
| GeneOntologyMolecularFunction | ATPase-coupled monoatomic cation transmembrane transporter activity | 2.66e-04 | 62 | 184 | 5 | GO:0019829 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | MYH4 DNAH3 MYH8 ABCA2 GBP6 DNAH2 YTHDC2 DHX9 MDN1 ABCA6 RAB7A DDX53 ATP2B1 ATP2B2 ATP2B3 ATP2B4 KIF1C HSP90AB3P | 3.05e-04 | 775 | 184 | 18 | GO:0017111 |
| GeneOntologyMolecularFunction | transporter activity | ANO4 TTYH1 VMP1 ABCA2 TRPC7 SLC38A9 TPTE2 TRPC3 KCNK16 SLC39A10 PKD1L2 PKD1L3 TTPA CHRNA2 GRAMD1B SLC22A9 NALCN ABCA6 SLC5A12 ATP1B3 ATP2B1 ATP2B2 ATP2B3 ATP2B4 ANO3 | 3.36e-04 | 1289 | 184 | 25 | GO:0005215 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | ANO4 TTYH1 TRPC7 TPTE2 TRPC3 KCNK16 SLC39A10 PKD1L2 PKD1L3 CHRNA2 NALCN SLC5A12 ATP1B3 ATP2B1 ATP2B2 ATP2B3 ATP2B4 ANO3 | 4.01e-04 | 793 | 184 | 18 | GO:0015075 |
| GeneOntologyMolecularFunction | lipid transporter activity | 4.79e-04 | 196 | 184 | 8 | GO:0005319 | |
| GeneOntologyMolecularFunction | calcium-dependent ATPase activity | 5.01e-04 | 4 | 184 | 2 | GO:0030899 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 5.67e-04 | 18 | 184 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | MYH4 DNAH3 MYH8 ABCA2 GBP6 DNAH2 YTHDC2 DHX9 MDN1 ABCA6 RAB7A DDX53 ATP2B1 ATP2B2 ATP2B3 ATP2B4 KIF1C HSP90AB3P | 7.74e-04 | 839 | 184 | 18 | GO:0016462 |
| GeneOntologyMolecularFunction | intracellularly calcium-gated channel activity | 7.82e-04 | 20 | 184 | 3 | GO:0141147 | |
| GeneOntologyMolecularFunction | intracellularly calcium-gated chloride channel activity | 7.82e-04 | 20 | 184 | 3 | GO:0005229 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | MYH4 DNAH3 MYH8 ABCA2 GBP6 DNAH2 YTHDC2 DHX9 MDN1 ABCA6 RAB7A DDX53 ATP2B1 ATP2B2 ATP2B3 ATP2B4 KIF1C HSP90AB3P | 7.84e-04 | 840 | 184 | 18 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | MYH4 DNAH3 MYH8 ABCA2 GBP6 DNAH2 YTHDC2 DHX9 MDN1 ABCA6 RAB7A DDX53 ATP2B1 ATP2B2 ATP2B3 ATP2B4 KIF1C HSP90AB3P | 7.84e-04 | 840 | 184 | 18 | GO:0016818 |
| GeneOntologyMolecularFunction | lipid binding | LPAR3 FGD2 SLC38A9 ANXA1 ESRRA ESRRB ESRRG TTPA EPN2 PGR GRAMD1B OTC CLEC4F ARHGAP44 FER ZFYVE26 PRKCI EPN1 MCTP2 UNC13A | 8.13e-04 | 988 | 184 | 20 | GO:0008289 |
| GeneOntologyMolecularFunction | phospholipid scramblase activity | 1.19e-03 | 23 | 184 | 3 | GO:0017128 | |
| GeneOntologyMolecularFunction | 3'-5' RNA helicase activity | 1.24e-03 | 6 | 184 | 2 | GO:0034458 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 1.24e-03 | 51 | 184 | 4 | GO:0140303 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | TTYH1 TRPC7 TRPC3 KCNK16 SLC39A10 PKD1L2 PKD1L3 CHRNA2 NALCN SLC5A12 ATP1B3 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 1.29e-03 | 664 | 184 | 15 | GO:0008324 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ANO4 TTYH1 ABCA2 TRPC7 SLC38A9 TPTE2 TRPC3 KCNK16 SLC39A10 PKD1L2 PKD1L3 CHRNA2 SLC22A9 NALCN ABCA6 SLC5A12 ATP1B3 ATP2B1 ATP2B2 ATP2B3 ATP2B4 ANO3 | 1.30e-03 | 1180 | 184 | 22 | GO:0022857 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | MYH6 MYH8 PDE6A TPTE2 MRPL44 SLFN14 PTPN7 PTPN14 PTPRA PTPRC PTPRD PTPRE PTPRF PTPRO PTPRS CES3 PLCE1 | 1.32e-03 | 807 | 184 | 17 | GO:0016788 |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 1.34e-03 | 178 | 184 | 7 | GO:0015399 | |
| GeneOntologyMolecularFunction | steroid binding | 1.47e-03 | 133 | 184 | 6 | GO:0005496 | |
| GeneOntologyMolecularFunction | phospholipid binding | LPAR3 FGD2 ANXA1 TTPA EPN2 GRAMD1B OTC ARHGAP44 ZFYVE26 PRKCI EPN1 MCTP2 UNC13A | 1.76e-03 | 548 | 184 | 13 | GO:0005543 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | ANO4 TTYH1 TRPC7 TRPC3 KCNK16 SLC39A10 PKD1L2 PKD1L3 NALCN SLC5A12 ATP1B3 ATP2B1 ATP2B2 ATP2B3 ATP2B4 ANO3 | 1.79e-03 | 758 | 184 | 16 | GO:0015318 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | TTYH1 TRPC7 TRPC3 KCNK16 SLC39A10 PKD1L2 PKD1L3 NALCN SLC5A12 ATP1B3 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 2.07e-03 | 627 | 184 | 14 | GO:0022890 |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 2.13e-03 | 28 | 184 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | nuclear receptor activity | 2.28e-03 | 60 | 184 | 4 | GO:0004879 | |
| GeneOntologyMolecularFunction | ligand-activated transcription factor activity | 2.42e-03 | 61 | 184 | 4 | GO:0098531 | |
| GeneOntologyMolecularFunction | protein domain specific binding | MPP2 ESRRA ESRRG BCL2L1 PLXND1 STXBP1 UBR5 MTOR SNTG2 SENP2 DMD ATP2B1 ATP2B2 ATP2B3 ATP2B4 UNC13A HSP90AB3P | 3.07e-03 | 875 | 184 | 17 | GO:0019904 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | ANO4 TTYH1 TRPC7 TPTE2 TRPC3 KCNK16 PKD1L2 PKD1L3 CHRNA2 NALCN ANO3 | 3.63e-03 | 459 | 184 | 11 | GO:0005216 |
| GeneOntologyMolecularFunction | spectrin binding | 3.73e-03 | 34 | 184 | 3 | GO:0030507 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 3.99e-03 | 70 | 184 | 4 | GO:0003777 | |
| GeneOntologyBiologicalProcess | muscle filament sliding | 7.42e-06 | 15 | 182 | 4 | GO:0030049 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | VMP1 TRPC7 TRPC3 PKD1L2 PKD1L3 PTPRC NALCN DMD OGA ATP2B1 ATP2B2 ATP2B3 ATP2B4 PLCE1 | 1.06e-05 | 392 | 182 | 14 | GO:0070588 |
| GeneOntologyBiologicalProcess | actin-myosin filament sliding | 1.63e-05 | 18 | 182 | 4 | GO:0033275 | |
| GeneOntologyBiologicalProcess | protein dephosphorylation | SLC39A10 PTPN7 PTPN14 PTPRA PTPRC PTPRD PTPRE PTPRF PTPRO PTPRS MTOR | 1.79e-05 | 256 | 182 | 11 | GO:0006470 |
| GeneOntologyBiologicalProcess | cell surface receptor protein tyrosine phosphatase signaling pathway | 2.30e-05 | 7 | 182 | 3 | GO:0007185 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class I | 2.93e-05 | 41 | 182 | 5 | GO:0002474 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I | 4.55e-05 | 23 | 182 | 4 | GO:0019885 | |
| GeneOntologyBiologicalProcess | calcium ion transport | VMP1 LPAR3 TRPC7 TRPC3 PKD1L2 PKD1L3 PTPRC NALCN DMD OGA ATP2B1 ATP2B2 ATP2B3 ATP2B4 PLCE1 | 4.82e-05 | 509 | 182 | 15 | GO:0006816 |
| GeneOntologyBiologicalProcess | dephosphorylation | TPTE2 SLC39A10 PTPN7 PTPN14 PTPRA PTPRC PTPRD PTPRE PTPRF PTPRO PTPRS MTOR | 6.28e-05 | 347 | 182 | 12 | GO:0016311 |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen | 6.42e-05 | 25 | 182 | 4 | GO:0002483 | |
| GeneOntologyBiologicalProcess | positive regulation of transport | SOX4 DENND5B VMP1 NRDE2 LPAR3 ANXA1 SYNE1 ITSN1 TRPC3 BCL2L1 DHX9 GHRH PTPRC STXBP1 UBR5 RAB7A PRKCI DMD ATP1B3 OGA ATP2B1 ATP2B2 UNC13A | 8.37e-05 | 1081 | 182 | 23 | GO:0051050 |
| GeneOntologyBiologicalProcess | regulation of cytosolic calcium ion concentration | 9.99e-05 | 84 | 182 | 6 | GO:0051480 | |
| GeneOntologyBiologicalProcess | regulation of cardiac conduction | 1.17e-04 | 29 | 182 | 4 | GO:1903779 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | ANO4 TTYH1 VMP1 TRPC7 TPTE2 TRPC3 KCNK16 SLC39A10 PKD1L2 PKD1L3 CHRNA2 PTPRC NALCN MTOR DMD ATP1B3 OGA ATP2B1 ATP2B2 ATP2B3 ATP2B4 ANO3 PLCE1 | 1.33e-04 | 1115 | 182 | 23 | GO:0034220 |
| GeneOntologyBiologicalProcess | positive regulation of growth hormone secretion | 1.40e-04 | 12 | 182 | 3 | GO:0060124 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous antigen | 1.74e-04 | 32 | 182 | 4 | GO:0019883 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | ANO4 TTYH1 VMP1 LPAR3 TRPC7 TPTE2 TRPC3 KCNK16 SLC39A10 PKD1L2 PKD1L3 CHRNA2 SLC22A9 PTPRC NALCN MTOR SLC5A12 DMD ATP1B3 OGA ATP2B1 ATP2B2 ATP2B3 ATP2B4 ANO3 PLCE1 | 1.88e-04 | 1374 | 182 | 26 | GO:0006811 |
| GeneOntologyBiologicalProcess | blood circulation | MYH6 ERAP1 SGCD TMEM161B ITGA9 SGCZ NAMPT ERAP2 PTPRO MTOR DMD ATP2B1 ATP2B2 ATP2B3 ATP2B4 SOD3 | 2.11e-04 | 648 | 182 | 16 | GO:0008015 |
| GeneOntologyBiologicalProcess | muscle contraction | MYH1 MYH2 MYH4 MYH6 MYH8 MYH13 SGCD MTOR DMD ATP2B1 ATP2B4 MYBPC2 | 2.37e-04 | 400 | 182 | 12 | GO:0006936 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | ANO4 TTYH1 VMP1 TRPC7 TRPC3 KCNK16 SLC39A10 PKD1L2 PKD1L3 PTPRC NALCN MTOR DMD ATP1B3 OGA ATP2B1 ATP2B2 ATP2B3 ATP2B4 ANO3 PLCE1 | 2.61e-04 | 1017 | 182 | 21 | GO:0098660 |
| GeneOntologyBiologicalProcess | circulatory system process | MYH6 ABCA2 ERAP1 SGCD TMEM161B ITGA9 SGCZ NAMPT ERAP2 PTPRO MTOR DMD ATP2B1 ATP2B2 ATP2B3 ATP2B4 SOD3 | 2.78e-04 | 733 | 182 | 17 | GO:0003013 |
| GeneOntologyBiologicalProcess | negative regulation of muscle adaptation | 2.84e-04 | 15 | 182 | 3 | GO:0014745 | |
| GeneOntologyCellularComponent | myosin filament | 1.59e-09 | 25 | 185 | 7 | GO:0032982 | |
| GeneOntologyCellularComponent | muscle myosin complex | 3.30e-09 | 16 | 185 | 6 | GO:0005859 | |
| GeneOntologyCellularComponent | myosin II complex | 1.42e-07 | 28 | 185 | 6 | GO:0016460 | |
| GeneOntologyCellularComponent | synaptic membrane | MPP2 ANXA1 SYNE1 ITSN1 CLSTN2 CHRNA2 PTPRA STXBP1 PTPRD PTPRF OTOF PTPRO PTPRS DMD EPN1 ATP2B1 ATP2B2 ATP2B3 ATP2B4 UNC13A | 2.54e-07 | 583 | 185 | 20 | GO:0097060 |
| GeneOntologyCellularComponent | myosin complex | 1.35e-05 | 59 | 185 | 6 | GO:0016459 | |
| GeneOntologyCellularComponent | dystrophin-associated glycoprotein complex | 2.58e-05 | 20 | 185 | 4 | GO:0016010 | |
| GeneOntologyCellularComponent | myofibril | MYH1 MYH2 MYH4 MYH6 MYH8 IGFN1 MYH13 SYNE1 DMD ATP2B4 MYBPC2 | 3.34e-05 | 273 | 185 | 11 | GO:0030016 |
| GeneOntologyCellularComponent | presynaptic membrane | ITSN1 STXBP1 PTPRD OTOF PTPRS EPN1 ATP2B1 ATP2B2 ATP2B3 ATP2B4 UNC13A | 3.81e-05 | 277 | 185 | 11 | GO:0042734 |
| GeneOntologyCellularComponent | contractile muscle fiber | MYH1 MYH2 MYH4 MYH6 MYH8 IGFN1 MYH13 SYNE1 DMD ATP2B4 MYBPC2 | 5.77e-05 | 290 | 185 | 11 | GO:0043292 |
| GeneOntologyCellularComponent | glycoprotein complex | 6.49e-05 | 25 | 185 | 4 | GO:0090665 | |
| GeneOntologyCellularComponent | sarcomere | 7.85e-05 | 249 | 185 | 10 | GO:0030017 | |
| GeneOntologyCellularComponent | exocytic vesicle membrane | 1.99e-04 | 179 | 185 | 8 | GO:0099501 | |
| GeneOntologyCellularComponent | synaptic vesicle membrane | 1.99e-04 | 179 | 185 | 8 | GO:0030672 | |
| GeneOntologyCellularComponent | presynaptic active zone | 2.65e-04 | 141 | 185 | 7 | GO:0048786 | |
| GeneOntologyCellularComponent | syntrophin complex | 4.62e-04 | 4 | 185 | 2 | GO:0016013 | |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 6.44e-04 | 78 | 185 | 5 | GO:0048787 | |
| GeneOntologyCellularComponent | presynapse | ITSN1 BCL2L1 PGR GHRH STXBP1 PTPRD OTOF PTPRS ARHGAP44 RAB7A DMD EPN1 MCTP2 ATP2B1 ATP2B2 ATP2B3 ATP2B4 UNC13A | 9.13e-04 | 886 | 185 | 18 | GO:0098793 |
| GeneOntologyCellularComponent | glutamatergic synapse | MPP2 ITSN1 CLSTN2 PLXND1 STXBP1 PTPRD PTPRO PTPRS MTOR ARHGAP44 RAB7A PRKCI ATP2B1 ATP2B2 ATP2B3 ATP2B4 UNC13A | 9.78e-04 | 817 | 185 | 17 | GO:0098978 |
| GeneOntologyCellularComponent | sarcoglycan complex | 1.14e-03 | 6 | 185 | 2 | GO:0016012 | |
| GeneOntologyCellularComponent | nuclear stress granule | 1.14e-03 | 6 | 185 | 2 | GO:0097165 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 1.36e-03 | 25 | 185 | 3 | GO:0005858 | |
| GeneOntologyCellularComponent | dendritic spine | 1.45e-03 | 242 | 185 | 8 | GO:0043197 | |
| GeneOntologyCellularComponent | dystroglycan complex | 1.59e-03 | 7 | 185 | 2 | GO:0016011 | |
| GeneOntologyCellularComponent | neuron spine | 1.65e-03 | 247 | 185 | 8 | GO:0044309 | |
| GeneOntologyCellularComponent | cell leading edge | MPP2 FGD2 ITSN1 PLXND1 PTPRO ARHGAP44 FER PRKCI DMD ATP2B1 ATP2B2 PLCE1 | 1.71e-03 | 500 | 185 | 12 | GO:0031252 |
| GeneOntologyCellularComponent | Schaffer collateral - CA1 synapse | 2.61e-03 | 155 | 185 | 6 | GO:0098685 | |
| GeneOntologyCellularComponent | excitatory synapse | 2.64e-03 | 107 | 185 | 5 | GO:0060076 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 2.78e-03 | 157 | 185 | 6 | GO:0098839 | |
| GeneOntologyCellularComponent | ribbon synapse | 2.80e-03 | 32 | 185 | 3 | GO:0097470 | |
| GeneOntologyCellularComponent | inner dynein arm | 3.35e-03 | 10 | 185 | 2 | GO:0036156 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 3.36e-03 | 405 | 185 | 10 | GO:0045211 | |
| Domain | PTPc | 3.80e-11 | 36 | 177 | 9 | SM00194 | |
| Domain | TYR_PHOSPHATASE_PTP | 8.34e-11 | 39 | 177 | 9 | PS50055 | |
| Domain | PTPase_domain | 1.36e-10 | 41 | 177 | 9 | IPR000242 | |
| Domain | Y_phosphatase | 1.36e-10 | 41 | 177 | 9 | PF00102 | |
| Domain | Tyr_Pase_AS | TPTE2 PTPN7 PTPN14 PTPRA PTPRC PTPRD PTPRE PTPRF PTPRO PTPRS | 1.68e-09 | 73 | 177 | 10 | IPR016130 |
| Domain | Myosin_N | 3.10e-09 | 15 | 177 | 6 | PF02736 | |
| Domain | Myosin_N | 3.10e-09 | 15 | 177 | 6 | IPR004009 | |
| Domain | PTPc_motif | 4.21e-09 | 59 | 177 | 9 | SM00404 | |
| Domain | Tyr_Pase_cat | 4.21e-09 | 59 | 177 | 9 | IPR003595 | |
| Domain | ATP_Ca_trans_C | 7.80e-09 | 4 | 177 | 4 | IPR022141 | |
| Domain | ATP_Ca_trans_C | 7.80e-09 | 4 | 177 | 4 | PF12424 | |
| Domain | P-type_ATPase_IIB | 7.80e-09 | 4 | 177 | 4 | IPR006408 | |
| Domain | TYR_PHOSPHATASE_1 | TPTE2 PTPN7 PTPN14 PTPRA PTPRC PTPRD PTPRE PTPRF PTPRO PTPRS | 8.61e-09 | 86 | 177 | 10 | PS00383 |
| Domain | TYR_PHOSPHATASE_dom | TPTE2 PTPN7 PTPN14 PTPRA PTPRC PTPRD PTPRE PTPRF PTPRO PTPRS | 9.65e-09 | 87 | 177 | 10 | IPR000387 |
| Domain | TYR_PHOSPHATASE_2 | TPTE2 PTPN7 PTPN14 PTPRA PTPRC PTPRD PTPRE PTPRF PTPRO PTPRS | 9.65e-09 | 87 | 177 | 10 | PS50056 |
| Domain | Myosin_tail_1 | 1.12e-08 | 18 | 177 | 6 | PF01576 | |
| Domain | Myosin_tail | 1.12e-08 | 18 | 177 | 6 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 1.63e-08 | 19 | 177 | 6 | IPR027401 | |
| Domain | - | 1.63e-08 | 19 | 177 | 6 | 4.10.270.10 | |
| Domain | - | TPTE2 PTPN7 PTPN14 PTPRA PTPRC PTPRD PTPRE PTPRF PTPRO PTPRS | 1.67e-08 | 92 | 177 | 10 | 3.90.190.10 |
| Domain | Prot-tyrosine_phosphatase-like | TPTE2 PTPN7 PTPN14 PTPRA PTPRC PTPRD PTPRE PTPRF PTPRO PTPRS | 3.41e-08 | 99 | 177 | 10 | IPR029021 |
| Domain | Oest-rel_rcp | 8.37e-07 | 3 | 177 | 3 | IPR027289 | |
| Domain | Myosin_head_motor_dom | 1.43e-06 | 38 | 177 | 6 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 1.43e-06 | 38 | 177 | 6 | PS51456 | |
| Domain | Myosin_head | 1.43e-06 | 38 | 177 | 6 | PF00063 | |
| Domain | MYSc | 1.43e-06 | 38 | 177 | 6 | SM00242 | |
| Domain | Oest_rcpt/oest-rel_rcp | 8.25e-06 | 5 | 177 | 3 | IPR024178 | |
| Domain | ATPase_P-typ_TM_dom | 1.30e-05 | 16 | 177 | 4 | IPR023298 | |
| Domain | - | 1.30e-05 | 16 | 177 | 4 | 1.20.1110.10 | |
| Domain | ATPase_P-typ_cation-transptr_C | 1.69e-05 | 17 | 177 | 4 | IPR006068 | |
| Domain | Cation_ATPase_C | 1.69e-05 | 17 | 177 | 4 | PF00689 | |
| Domain | Cation_ATPase_N | 2.15e-05 | 18 | 177 | 4 | PF00690 | |
| Domain | Cation_ATPase_N | 2.15e-05 | 18 | 177 | 4 | SM00831 | |
| Domain | fn3 | 2.45e-05 | 162 | 177 | 9 | PF00041 | |
| Domain | ATPase_P-typ_cation-transptr_N | 2.70e-05 | 19 | 177 | 4 | IPR004014 | |
| Domain | P-loop_NTPase | MPP2 MYH1 MYH2 MYH4 DNAH3 MYH6 MYH8 ABCA2 GBP6 MYH13 DTYMK DNAH2 YTHDC2 SLFN14 DHX9 RABL6 MDN1 ABCA6 RAB7A DDX53 KIF1C | 5.54e-05 | 848 | 177 | 21 | IPR027417 |
| Domain | IQ | 5.72e-05 | 71 | 177 | 6 | PF00612 | |
| Domain | FN3 | 6.93e-05 | 185 | 177 | 9 | SM00060 | |
| Domain | Tyr_Pase_rcpt_a/e-type | 8.93e-05 | 2 | 177 | 2 | IPR016336 | |
| Domain | ATP2B1/4 | 8.93e-05 | 2 | 177 | 2 | IPR030319 | |
| Domain | Retinoid-X_rcpt/HNF4 | 9.56e-05 | 10 | 177 | 3 | IPR000003 | |
| Domain | IQ | 1.20e-04 | 81 | 177 | 6 | SM00015 | |
| Domain | FN3 | 1.21e-04 | 199 | 177 | 9 | PS50853 | |
| Domain | FN3_dom | 1.75e-04 | 209 | 177 | 9 | IPR003961 | |
| Domain | IQ_motif_EF-hand-BS | 2.14e-04 | 90 | 177 | 6 | IPR000048 | |
| Domain | IQ | 2.57e-04 | 93 | 177 | 6 | PS50096 | |
| Domain | ATPase_dyneun-rel_AAA | 2.82e-04 | 14 | 177 | 3 | IPR011704 | |
| Domain | AAA_5 | 2.82e-04 | 14 | 177 | 3 | PF07728 | |
| Domain | ATPase_P-typ_cyto_domN | 3.25e-04 | 35 | 177 | 4 | IPR023299 | |
| Domain | ATPase_P-typ_P_site | 3.62e-04 | 36 | 177 | 4 | IPR018303 | |
| Domain | P_typ_ATPase | 3.62e-04 | 36 | 177 | 4 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 3.62e-04 | 36 | 177 | 4 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 4.03e-04 | 37 | 177 | 4 | IPR008250 | |
| Domain | E1-E2_ATPase | 4.03e-04 | 37 | 177 | 4 | PF00122 | |
| Domain | Sarcoglycan_1 | 5.29e-04 | 4 | 177 | 2 | PF04790 | |
| Domain | Sarcoglycan | 5.29e-04 | 4 | 177 | 2 | IPR006875 | |
| Domain | Znf_hrmn_rcpt | 9.33e-04 | 46 | 177 | 4 | IPR001628 | |
| Domain | NUCLEAR_REC_DBD_2 | 9.33e-04 | 46 | 177 | 4 | PS51030 | |
| Domain | NUCLEAR_REC_DBD_1 | 9.33e-04 | 46 | 177 | 4 | PS00031 | |
| Domain | ZnF_C4 | 9.33e-04 | 46 | 177 | 4 | SM00399 | |
| Domain | zf-C4 | 9.33e-04 | 46 | 177 | 4 | PF00105 | |
| Domain | Nuclear_hrmn_rcpt | 9.33e-04 | 46 | 177 | 4 | IPR001723 | |
| Domain | - | 9.82e-04 | 21 | 177 | 3 | 2.60.60.20 | |
| Domain | MHC_I | 9.82e-04 | 21 | 177 | 3 | PF00129 | |
| Domain | PLAT | 9.82e-04 | 21 | 177 | 3 | PF01477 | |
| Domain | MHC_I_a_a1/a2 | 9.82e-04 | 21 | 177 | 3 | IPR001039 | |
| Domain | PLAT/LH2_dom | 9.82e-04 | 21 | 177 | 3 | IPR001024 | |
| Domain | PLAT | 9.82e-04 | 21 | 177 | 3 | PS50095 | |
| Domain | - | 1.01e-03 | 47 | 177 | 4 | 1.10.565.10 | |
| Domain | Nucl_hrmn_rcpt_lig-bd | 1.10e-03 | 48 | 177 | 4 | IPR000536 | |
| Domain | HOLI | 1.10e-03 | 48 | 177 | 4 | SM00430 | |
| Domain | Hormone_recep | 1.10e-03 | 48 | 177 | 4 | PF00104 | |
| Domain | TRP_2 | 1.31e-03 | 6 | 177 | 2 | PF08344 | |
| Domain | TRP_dom | 1.31e-03 | 6 | 177 | 2 | IPR013555 | |
| Domain | ENTH | 1.31e-03 | 6 | 177 | 2 | PF01417 | |
| Domain | - | 1.46e-03 | 24 | 177 | 3 | 3.30.500.10 | |
| Domain | MHC_I-like_Ag-recog | 1.46e-03 | 24 | 177 | 3 | IPR011161 | |
| Domain | Anoct_dimer | 1.82e-03 | 7 | 177 | 2 | PF16178 | |
| Domain | Anoct_dimer | 1.82e-03 | 7 | 177 | 2 | IPR032394 | |
| Domain | TRPC_channel | 1.82e-03 | 7 | 177 | 2 | IPR002153 | |
| Domain | ZnF_UBR1 | 1.82e-03 | 7 | 177 | 2 | SM00396 | |
| Domain | ZF_UBR | 1.82e-03 | 7 | 177 | 2 | PS51157 | |
| Domain | zf-UBR | 1.82e-03 | 7 | 177 | 2 | PF02207 | |
| Domain | Znf_UBR | 1.82e-03 | 7 | 177 | 2 | IPR003126 | |
| Domain | - | 2.08e-03 | 57 | 177 | 4 | 3.30.50.10 | |
| Domain | Znf_NHR/GATA | 2.22e-03 | 58 | 177 | 4 | IPR013088 | |
| Domain | ERAP1-like_C_dom | 2.41e-03 | 8 | 177 | 2 | IPR024571 | |
| Domain | ERAP1_C | 2.41e-03 | 8 | 177 | 2 | PF11838 | |
| Domain | ENTH | 3.08e-03 | 9 | 177 | 2 | PS50942 | |
| Domain | ENTH | 3.08e-03 | 9 | 177 | 2 | SM00273 | |
| Domain | ENTH | 3.82e-03 | 10 | 177 | 2 | IPR013809 | |
| Domain | Rap_GAP | 3.82e-03 | 10 | 177 | 2 | PF02145 | |
| Domain | Anoctamin | 3.82e-03 | 10 | 177 | 2 | PF04547 | |
| Domain | Anoctamin | 3.82e-03 | 10 | 177 | 2 | IPR007632 | |
| Domain | Hydrolase_3 | 3.82e-03 | 10 | 177 | 2 | PF08282 | |
| Domain | TRP_channel | 4.64e-03 | 11 | 177 | 2 | IPR004729 | |
| Domain | Rap_GAP_dom | 4.64e-03 | 11 | 177 | 2 | IPR000331 | |
| Domain | RAPGAP | 4.64e-03 | 11 | 177 | 2 | PS50085 | |
| Domain | PKD_channel | 4.64e-03 | 11 | 177 | 2 | PF08016 | |
| Domain | PKD1_2_channel | 4.64e-03 | 11 | 177 | 2 | IPR013122 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 3.11e-07 | 27 | 149 | 6 | MM15053 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 3.92e-07 | 28 | 149 | 6 | M924 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 7.00e-07 | 70 | 149 | 8 | M12294 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | ANO4 TTYH1 TRPC7 TRPC3 NALCN ATP1B3 ATP2B1 ATP2B2 ATP2B3 ATP2B4 ANO3 | 2.61e-06 | 176 | 149 | 11 | MM15718 |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | ANO4 TTYH1 TRPC7 TRPC3 NALCN ATP1B3 ATP2B1 ATP2B2 ATP2B3 ATP2B4 ANO3 | 3.81e-06 | 183 | 149 | 11 | M997 |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 5.56e-06 | 12 | 149 | 4 | M27326 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | MYH6 MYH8 KCNK16 DMD ATP1B3 ATP2B1 ATP2B2 ATP2B3 ATP2B4 MYBPC2 | 9.92e-06 | 165 | 149 | 10 | MM15026 |
| Pathway | REACTOME_MUSCLE_CONTRACTION | MYH6 MYH8 ANXA1 KCNK16 DMD ATP1B3 ATP2B1 ATP2B2 ATP2B3 ATP2B4 MYBPC2 | 1.03e-05 | 203 | 149 | 11 | M5485 |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 1.11e-05 | 14 | 149 | 4 | MM15052 | |
| Pathway | KEGG_TIGHT_JUNCTION | 7.87e-05 | 132 | 149 | 8 | M11355 | |
| Pathway | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | 1.46e-04 | 48 | 149 | 5 | MM14987 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 1.50e-04 | 76 | 149 | 6 | MM15051 | |
| Pathway | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | 2.35e-04 | 53 | 149 | 5 | M8276 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 2.57e-04 | 54 | 149 | 5 | M27460 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 2.57e-04 | 54 | 149 | 5 | MM15202 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 2.80e-04 | 55 | 149 | 5 | M971 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 2.96e-04 | 86 | 149 | 6 | M916 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 3.32e-04 | 57 | 149 | 5 | MM15643 | |
| Pathway | REACTOME_STRIATED_MUSCLE_CONTRACTION | 4.86e-04 | 35 | 149 | 4 | MM15005 | |
| Pathway | REACTOME_STRIATED_MUSCLE_CONTRACTION | 5.43e-04 | 36 | 149 | 4 | M18647 | |
| Pathway | WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION | 5.43e-04 | 36 | 149 | 4 | M39831 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 6.30e-04 | 99 | 149 | 6 | MM14910 | |
| Pathway | WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY | 6.69e-04 | 38 | 149 | 4 | M39549 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 7.77e-04 | 103 | 149 | 6 | MM15196 | |
| Pubmed | 1.46e-13 | 7 | 185 | 6 | 12376545 | ||
| Pubmed | Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved. | 2.41e-11 | 6 | 185 | 5 | 10077619 | |
| Pubmed | 8.40e-11 | 7 | 185 | 5 | 1454056 | ||
| Pubmed | 8.40e-11 | 7 | 185 | 5 | 35210422 | ||
| Pubmed | 8.40e-11 | 7 | 185 | 5 | 16819597 | ||
| Pubmed | Protein tyrosine phosphatases expression during development of mouse superior colliculus. | 2.46e-10 | 17 | 185 | 6 | 19727691 | |
| Pubmed | Cell-specific expression of plasma membrane calcium ATPase isoforms in retinal neurons. | 7.75e-10 | 4 | 185 | 4 | 12209837 | |
| Pubmed | 7.75e-10 | 4 | 185 | 4 | 12784250 | ||
| Pubmed | 7.75e-10 | 4 | 185 | 4 | 23413890 | ||
| Pubmed | Quantitative analysis of alternative splicing options of human plasma membrane calcium pump genes. | 7.75e-10 | 4 | 185 | 4 | 8245032 | |
| Pubmed | Quantitative analysis of alternative splicing options of human plasma membrane calcium pump genes. | 7.75e-10 | 4 | 185 | 4 | 7989379 | |
| Pubmed | Role of alternative splicing in generating isoform diversity among plasma membrane calcium pumps. | 7.75e-10 | 4 | 185 | 4 | 11152753 | |
| Pubmed | PMCA1 depletion in mouse eggs amplifies calcium signaling and impacts offspring growth†. | 7.75e-10 | 4 | 185 | 4 | 36130203 | |
| Pubmed | Developmental expression of the four plasma membrane calcium ATPase (Pmca) genes in the mouse. | 7.75e-10 | 4 | 185 | 4 | 10434059 | |
| Pubmed | 7.75e-10 | 4 | 185 | 4 | 10388558 | ||
| Pubmed | 7.75e-10 | 4 | 185 | 4 | 15101689 | ||
| Pubmed | 7.75e-10 | 4 | 185 | 4 | 10577388 | ||
| Pubmed | Structural organization, ion transport, and energy transduction of P-type ATPases. | 7.75e-10 | 4 | 185 | 4 | 8634322 | |
| Pubmed | 1.45e-09 | 22 | 185 | 6 | 24301466 | ||
| Pubmed | 1.82e-09 | 11 | 185 | 5 | 7832766 | ||
| Pubmed | 3.86e-09 | 5 | 185 | 4 | 10777529 | ||
| Pubmed | Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro. | 3.86e-09 | 5 | 185 | 4 | 3829126 | |
| Pubmed | Myosin heavy chain isoforms of the murine masseter muscle during pre- and post-natal development. | 3.86e-09 | 5 | 185 | 4 | 12919077 | |
| Pubmed | 3.86e-09 | 5 | 185 | 4 | 6196357 | ||
| Pubmed | 3.86e-09 | 5 | 185 | 4 | 17938178 | ||
| Pubmed | 1.15e-08 | 6 | 185 | 4 | 1728586 | ||
| Pubmed | Cardiac excitation-contraction coupling in the absence of Na(+) - Ca2+ exchange. | 1.15e-08 | 6 | 185 | 4 | 12767889 | |
| Pubmed | Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development. | 1.15e-08 | 6 | 185 | 4 | 10588881 | |
| Pubmed | RALGAPA1 SYNE1 ITSN1 HSPH1 MRPL44 SPTLC1 DNAJC21 SLC39A10 DHX9 GRAMD1B THADA PTPN14 MDN1 UBR5 ERAP2 CCDC138 FADS2 RAB7A UGGT2 SENP2 PRKCI ATP1B3 OGA ATP2B1 EIF2AK3 ATP2B4 CLUH | 2.62e-08 | 1487 | 185 | 27 | 33957083 | |
| Pubmed | ANKK1 is found in myogenic precursors and muscle fibers subtypes with glycolytic metabolism. | 2.68e-08 | 7 | 185 | 4 | 29758057 | |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 5.00e-08 | 38 | 185 | 6 | 30786075 | |
| Pubmed | A Tcf4-positive mesodermal population provides a prepattern for vertebrate limb muscle patterning. | 5.34e-08 | 8 | 185 | 4 | 14667415 | |
| Pubmed | 5.34e-08 | 8 | 185 | 4 | 3864153 | ||
| Pubmed | 5.34e-08 | 8 | 185 | 4 | 10951186 | ||
| Pubmed | ABCA2 ERAP1 VPS50 ST3GAL1 POLR3A DHX9 NUP205 GRAMD1B NCOR2 PCYOX1L MDN1 PTPRC INTS2 UBR5 MTOR FADS2 ITPRIP ETNK1 OGA MCTP2 ATP2B1 EIF2AK3 ATP2B4 | 7.45e-08 | 1168 | 185 | 23 | 19946888 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SOX4 ABCA2 SZT2 NICN1 ST3GAL1 PLXND1 TNRC6C RALGAPA2 TYK2 RABL6 NCOR2 THADA MDN1 PTPRF PTPRS MTOR ARHGAP44 MAD1L1 SENP2 ZFYVE26 CAMSAP1 SYMPK | 1.21e-07 | 1105 | 185 | 22 | 35748872 |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | VMP1 ABCA2 ERAP1 TMEM161B TMED5 HSPH1 SPTLC1 MR1 ST3GAL1 PLXND1 SLC39A10 GRAMD1B PCYOX1L THADA ERG28 PTPRF PTPRS FADS2 UGGT2 ATP1B3 ATP2B1 EIF2AK3 SYMPK | 1.22e-07 | 1201 | 185 | 23 | 35696571 |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | EHBP1 SPTLC1 SLC39A10 PTPN14 PTPRA STXBP1 PTPRF PTPRS RAB7A DMD ATP2B1 ATP2B3 ATP2B4 | 1.35e-07 | 377 | 185 | 13 | 38117590 |
| Pubmed | Transition of myosin heavy chain isoforms in human laryngeal abductors following denervation. | 1.48e-07 | 3 | 185 | 3 | 26059207 | |
| Pubmed | LAR receptor phospho-tyrosine phosphatases regulate NMDA-receptor responses. | 1.48e-07 | 3 | 185 | 3 | 31985401 | |
| Pubmed | 1.48e-07 | 3 | 185 | 3 | 20139422 | ||
| Pubmed | Intact synapse structure and function after combined knockout of PTPδ, PTPσ, and LAR. | 1.48e-07 | 3 | 185 | 3 | 33656439 | |
| Pubmed | 1.48e-07 | 3 | 185 | 3 | 29888756 | ||
| Pubmed | 1.48e-07 | 3 | 185 | 3 | 15598686 | ||
| Pubmed | 1.48e-07 | 3 | 185 | 3 | 9784606 | ||
| Pubmed | Specific isomyosin proportions in hyperexcitable and physiologically denervated mouse muscle. | 1.48e-07 | 3 | 185 | 3 | 15013776 | |
| Pubmed | 1.59e-07 | 10 | 185 | 4 | 19506036 | ||
| Pubmed | RGPD2 MYH1 MYH2 MYH4 MYH6 MYH8 DENND4A PDE6A MYH13 SYNE1 ITSN1 HSPH1 DNAH2 DNAJC21 NUP205 MDN1 STXBP1 SUSD1 CES3 UGGT2 DMD ATP2B1 ATP2B2 ATP2B3 MYBPC2 | 2.17e-07 | 1442 | 185 | 25 | 35575683 | |
| Pubmed | 2.48e-07 | 11 | 185 | 4 | 8136524 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | TPTE2 RANBP9 YTHDC2 NUP205 TYK2 PTPN7 PTPN14 PTPRA PTPRD PTPRF UBR5 PTPRO PTPRS MTOR RAB7A AKAP10 DMD ATP2B1 CLUH HSP90AB3P | 2.92e-07 | 974 | 185 | 20 | 28675297 |
| Pubmed | Liprins, a family of LAR transmembrane protein-tyrosine phosphatase-interacting proteins. | 3.71e-07 | 12 | 185 | 4 | 9624153 | |
| Pubmed | 4.32e-07 | 29 | 185 | 5 | 15071553 | ||
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | RGPD2 MYH1 MYH2 MYH4 MYH6 MYH8 MYH13 ERAP1 ANXA1 HSPH1 THADA MDN1 UBR5 MTOR ATP2B1 ATP2B4 | 4.34e-07 | 647 | 185 | 16 | 26618866 |
| Pubmed | Contractile protein gene expression in primary myotubes of embryonic mouse hindlimb muscles. | 5.34e-07 | 13 | 185 | 4 | 8404542 | |
| Pubmed | 5.90e-07 | 4 | 185 | 3 | 20357587 | ||
| Pubmed | 5.90e-07 | 4 | 185 | 3 | 1985022 | ||
| Pubmed | 5.90e-07 | 4 | 185 | 3 | 8524829 | ||
| Pubmed | Smooth muscle myosin light chain kinase expression in cardiac and skeletal muscle. | 5.90e-07 | 4 | 185 | 3 | 11029314 | |
| Pubmed | Modulation of skeletal muscle fiber type by mitogen-activated protein kinase signaling. | 5.90e-07 | 4 | 185 | 3 | 18417546 | |
| Pubmed | 5.90e-07 | 4 | 185 | 3 | 11023856 | ||
| Pubmed | 5.90e-07 | 4 | 185 | 3 | 18039682 | ||
| Pubmed | 5.90e-07 | 4 | 185 | 3 | 29940916 | ||
| Pubmed | 7.44e-07 | 14 | 185 | 4 | 27184118 | ||
| Pubmed | 7.44e-07 | 14 | 185 | 4 | 24938781 | ||
| Pubmed | RALGAPA1 TPTE2 SLC39A10 NCOR2 PTPN7 PTPN14 PTPRA PTPRC PTPRD PTPRE PTPRF PTPRS CCDC138 CSTF3 SENP2 PRKCI DMD ATP2B1 ATP2B4 SYMPK | 9.25e-07 | 1049 | 185 | 20 | 27880917 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | VMP1 SGCD DTYMK HSPH1 PLXND1 EPN2 NUP205 THADA PTPRA MDN1 PTPRF INTS2 PTPRS FADS2 RAB7A PDS5A UGGT2 EPN1 ATP2B4 SYMPK | 1.10e-06 | 1061 | 185 | 20 | 33845483 |
| Pubmed | 1.34e-06 | 16 | 185 | 4 | 8875997 | ||
| Pubmed | A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. | 1.34e-06 | 16 | 185 | 4 | 19922871 | |
| Pubmed | 1.47e-06 | 5 | 185 | 3 | 18509053 | ||
| Pubmed | Detection of Gene and Protein Expression in Mouse Embryos and Tissue Sections. | 1.47e-06 | 5 | 185 | 3 | 30737693 | |
| Pubmed | 1.47e-06 | 5 | 185 | 3 | 22357843 | ||
| Pubmed | Intersectin, a novel adaptor protein with two Eps15 homology and five Src homology 3 domains. | 1.47e-06 | 5 | 185 | 3 | 9813051 | |
| Pubmed | 1.75e-06 | 17 | 185 | 4 | 36230906 | ||
| Pubmed | IKKα and alternative NF-κB regulate PGC-1β to promote oxidative muscle metabolism. | 1.75e-06 | 17 | 185 | 4 | 22351927 | |
| Pubmed | 2.01e-06 | 39 | 185 | 5 | 38690566 | ||
| Pubmed | 2.93e-06 | 6 | 185 | 3 | 19273906 | ||
| Pubmed | 2.93e-06 | 6 | 185 | 3 | 12763866 | ||
| Pubmed | Parkin degrades estrogen-related receptors to limit the expression of monoamine oxidases. | 2.93e-06 | 6 | 185 | 3 | 21177257 | |
| Pubmed | 2.93e-06 | 6 | 185 | 3 | 23836911 | ||
| Pubmed | Structural diversity and evolution of human receptor-like protein tyrosine phosphatases. | 2.93e-06 | 6 | 185 | 3 | 2170109 | |
| Pubmed | 2.93e-06 | 6 | 185 | 3 | 20417199 | ||
| Pubmed | 2.93e-06 | 6 | 185 | 3 | 16439465 | ||
| Pubmed | Zeta-sarcoglycan, a novel component of the sarcoglycan complex, is reduced in muscular dystrophy. | 2.93e-06 | 6 | 185 | 3 | 12189167 | |
| Pubmed | A role for Insulin-like growth factor 2 in specification of the fast skeletal muscle fibre. | 2.93e-06 | 6 | 185 | 3 | 17559643 | |
| Pubmed | EHBP1 SPTLC1 SLC39A10 RALGAPA2 EPN2 PTPN14 STXBP1 PRKCI DMD ATP1B3 ATP2B1 ATP2B4 | 3.01e-06 | 421 | 185 | 12 | 36976175 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | RALGAPA1 AKAP17A RANBP9 YTHDC2 TNRC6C SLC39A10 MDN1 INTS2 UBR5 MTOR FADS2 RAB7A UGGT2 IL17RA ATP2B1 ATP2B4 | 3.15e-06 | 754 | 185 | 16 | 33060197 |
| Pubmed | MPP2 RGPD2 SYNE1 ITSN1 RANBP9 NCOR2 MDN1 PTPRD UBR5 PTPRS MTOR ARHGAP44 MAD1L1 RAB7A PRKCI CAMSAP1 ATP2B4 UNC13A | 4.39e-06 | 963 | 185 | 18 | 28671696 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | RALGAPA1 EHBP1 LPAR3 HYKK SLC38A9 ST3GAL1 TNRC6C BRWD3 TYK2 NCOR2 PCYOX1L THADA PTPRE INTS2 PTPRS ARHGAP44 MAD1L1 CSTF3 RAB7A SNTG2 PRKCI MCTP2 ATP2B1 | 4.78e-06 | 1489 | 185 | 23 | 28611215 |
| Pubmed | 5.10e-06 | 7 | 185 | 3 | 29073098 | ||
| Pubmed | Transmembrane homodimerization of receptor-like protein tyrosine phosphatases. | 5.10e-06 | 7 | 185 | 3 | 15978577 | |
| Pubmed | 5.10e-06 | 7 | 185 | 3 | 1932742 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DENND4A SYNE1 HSPH1 MRPL44 SPTLC1 YTHDC2 POLR3A DHX9 NUP205 THADA NAMPT MDN1 MTOR SERPINB3 CSTF3 RAB7A PDS5A PRKCI ATP1B3 ATP2B1 ATP2B3 CLUH | 7.89e-06 | 1425 | 185 | 22 | 30948266 |
| Pubmed | 8.13e-06 | 8 | 185 | 3 | 33667029 | ||
| Pubmed | 8.13e-06 | 8 | 185 | 3 | 37591863 | ||
| Pubmed | 8.13e-06 | 8 | 185 | 3 | 26993635 | ||
| Pubmed | 8.13e-06 | 8 | 185 | 3 | 36200826 | ||
| Pubmed | 8.13e-06 | 8 | 185 | 3 | 28637841 | ||
| Pubmed | MPP2 RALGAPA1 MYH6 ANXA1 SYNE1 ITSN1 HSPH1 YTHDC2 EPN2 DHX9 GRAMD1B PTPRA STXBP1 PTPRS ARHGAP44 RAB7A DMD ATP2B1 ATP2B2 ATP2B3 ATP2B4 UNC13A | 8.42e-06 | 1431 | 185 | 22 | 37142655 | |
| Pubmed | 1.02e-05 | 92 | 185 | 6 | 20301317 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | MYH1 UBQLNL MYH4 DNAH3 TAS1R3 ITSN1 HSPH1 DNAH2 FAM186B DHX9 NUP205 OTC MDN1 PDS5A SYMPK | 1.04e-05 | 736 | 185 | 15 | 29676528 |
| Interaction | OPALIN interactions | ERAP1 VPS50 NUP205 THADA MDN1 PTPRD PTPRF INTS2 MTOR PDS5A ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 6.07e-09 | 209 | 180 | 14 | int:OPALIN |
| Interaction | P2RY8 interactions | VMP1 ABCA2 ERAP1 SLC39A10 NUP205 THADA INTS2 MTOR ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 7.58e-08 | 179 | 180 | 12 | int:P2RY8 |
| Interaction | NPTN interactions | NBEAL1 VPS50 THADA MDN1 MTOR SERPINB3 SERPINB4 PDS5A ZFYVE26 ATP2B1 ATP2B2 ATP2B3 ATP2B4 SYMPK | 2.16e-07 | 278 | 180 | 14 | int:NPTN |
| Interaction | RSPH6A interactions | 5.10e-07 | 34 | 180 | 6 | int:RSPH6A | |
| Interaction | LAMTOR1 interactions | DENND5B EHBP1 DENND4A SZT2 SLC38A9 ITSN1 VPS50 SLC39A10 EPN2 RABL6 NAMPT PTPN14 PTPRD PTPRF RAB7A ZFYVE26 AKAP10 DMD EPN1 ATP2B1 ATP2B4 | 2.06e-06 | 722 | 180 | 21 | int:LAMTOR1 |
| Interaction | C17orf78 interactions | 2.88e-06 | 12 | 180 | 4 | int:C17orf78 | |
| Interaction | GPR45 interactions | VMP1 ABCA2 ERAP1 DTYMK TMED5 SLC39A10 NUP205 THADA MDN1 INTS2 MTOR PDS5A ATP2B2 | 3.17e-06 | 300 | 180 | 13 | int:GPR45 |
| Interaction | LILRB4 interactions | 4.47e-06 | 28 | 180 | 5 | int:LILRB4 | |
| Interaction | FPR1 interactions | 7.08e-06 | 147 | 180 | 9 | int:FPR1 | |
| Interaction | HSD17B6 interactions | 7.78e-06 | 15 | 180 | 4 | int:HSD17B6 | |
| Interaction | PTPRS interactions | 9.79e-06 | 153 | 180 | 9 | int:PTPRS | |
| Interaction | GPR182 interactions | ABCA2 ERAP1 TMEM161B TMED5 VPS50 SLC39A10 NUP205 THADA MDN1 MTOR CCDC138 PDS5A ATP2B1 ATP2B2 SYMPK | 1.52e-05 | 455 | 180 | 15 | int:GPR182 |
| Interaction | RAB4A interactions | RALGAPA1 EHBP1 DENND4A SYNE1 HSPH1 VPS50 SLC39A10 RABL6 SLC22A9 VPS13D RAB7A SENP2 AKAP10 PRKCI ATP2B1 | 1.60e-05 | 457 | 180 | 15 | int:RAB4A |
| Interaction | APLNR interactions | VMP1 ERAP1 TMEM161B VPS50 THADA MDN1 INTS2 MTOR PDS5A ATP2B4 | 2.08e-05 | 211 | 180 | 10 | int:APLNR |
| Interaction | SCN2B interactions | 2.30e-05 | 95 | 180 | 7 | int:SCN2B | |
| Interaction | HCRTR2 interactions | 2.42e-05 | 39 | 180 | 5 | int:HCRTR2 | |
| Interaction | TSPAN33 interactions | 2.49e-05 | 65 | 180 | 6 | int:TSPAN33 | |
| Interaction | RAB9A interactions | RALGAPA1 EHBP1 DENND4A SZT2 SLC38A9 VPS50 SLC39A10 NUP205 RABL6 VPS13D RAB7A SENP2 ZFYVE26 AKAP10 ATP2B1 EIF2AK3 ATP2B4 | 2.56e-05 | 595 | 180 | 17 | int:RAB9A |
| Interaction | CD83 interactions | 2.72e-05 | 66 | 180 | 6 | int:CD83 | |
| Interaction | CMKLR1 interactions | 3.42e-05 | 101 | 180 | 7 | int:CMKLR1 | |
| Interaction | FPR2 interactions | 3.43e-05 | 138 | 180 | 8 | int:FPR2 | |
| Interaction | PTPRE interactions | 3.51e-05 | 69 | 180 | 6 | int:PTPRE | |
| Interaction | CYP2B6 interactions | 3.80e-05 | 8 | 180 | 3 | int:CYP2B6 | |
| Interaction | AURKC interactions | 3.93e-05 | 43 | 180 | 5 | int:AURKC | |
| Interaction | PTPRQ interactions | 6.72e-05 | 25 | 180 | 4 | int:PTPRQ | |
| Interaction | GJA1 interactions | TTYH1 DENND5B EHBP1 MYH6 TAS1R3 ITSN1 KCNK16 SLC39A10 EPN2 PTPN14 STXBP1 MICB SENP2 ATP2B1 EIF2AK3 ATP2B4 | 7.19e-05 | 583 | 180 | 16 | int:GJA1 |
| Interaction | C5AR1 interactions | 7.46e-05 | 154 | 180 | 8 | int:C5AR1 | |
| Interaction | C3orf18 interactions | 7.85e-05 | 115 | 180 | 7 | int:C3orf18 | |
| Interaction | ITGA9 interactions | 7.89e-05 | 26 | 180 | 4 | int:ITGA9 | |
| Interaction | MCAM interactions | EHBP1 SPTLC1 SLC39A10 PTPN14 PTPRA STXBP1 PTPRF PTPRS MTOR RAB7A DMD ATP2B1 ATP2B3 ATP2B4 | 8.37e-05 | 468 | 180 | 14 | int:MCAM |
| Interaction | HRAS interactions | RALGAPA1 EHBP1 ANXA1 DTYMK ITSN1 SLC39A10 RALGAPA2 EPN2 PTPRA PTPRF MTOR RAB7A PDS5A PRKCI CAMSAP1 ATP2B1 ATP2B4 PLCE1 | 9.10e-05 | 725 | 180 | 18 | int:HRAS |
| Interaction | MYH8 interactions | 9.95e-05 | 52 | 180 | 5 | int:MYH8 | |
| Interaction | ENTPD7 interactions | 1.09e-04 | 53 | 180 | 5 | int:ENTPD7 | |
| Interaction | PTPRA interactions | 1.16e-04 | 164 | 180 | 8 | int:PTPRA | |
| Interaction | C19orf38 interactions | 1.22e-04 | 86 | 180 | 6 | int:C19orf38 | |
| Interaction | CDC42 interactions | RALGAPA1 EHBP1 UBR1 FGD2 SYNE1 ITSN1 SPTLC1 SLC39A10 DHX9 NUP205 RABL6 THADA PTPN14 ERG28 MDN1 PTPRF INTS2 PTPRS SERPINB3 ARHGAP44 RAB7A SENP2 PRKCI ATP1B3 ATP2B1 EIF2AK3 | 1.24e-04 | 1323 | 180 | 26 | int:CDC42 |
| Interaction | TPST2 interactions | 1.26e-04 | 124 | 180 | 7 | int:TPST2 | |
| Interaction | BMX interactions | 1.56e-04 | 90 | 180 | 6 | int:BMX | |
| Interaction | GOLIM4 interactions | 1.76e-04 | 92 | 180 | 6 | int:GOLIM4 | |
| Interaction | RHOJ interactions | RALGAPA1 EHBP1 VMP1 SPTLC1 SLC39A10 RALGAPA2 NUP205 PTPN14 MDN1 PTPRF PTPRS MTOR RAB7A PRKCI ATP1B3 ATP2B1 | 1.85e-04 | 633 | 180 | 16 | int:RHOJ |
| Interaction | OMG interactions | 1.88e-04 | 13 | 180 | 3 | int:OMG | |
| Interaction | FAM174A interactions | 1.90e-04 | 224 | 180 | 9 | int:FAM174A | |
| Interaction | RHOH interactions | RALGAPA1 EHBP1 SLC39A10 NUP205 VPS13D MDN1 PTPRF PTPRS MTOR RAB7A SENP2 PRKCI ATP1B3 ATP2B1 | 2.13e-04 | 512 | 180 | 14 | int:RHOH |
| Interaction | JAK3 interactions | 2.24e-04 | 136 | 180 | 7 | int:JAK3 | |
| Interaction | S1PR4 interactions | 2.34e-04 | 137 | 180 | 7 | int:S1PR4 | |
| Interaction | EPHA2 interactions | EHBP1 ANXA1 TPTE2 SPTLC1 SLC39A10 RALGAPA2 EPN2 PTPN7 PTPN14 STXBP1 PTPRO RAB7A PRKCI DMD ATP1B3 ATP2B1 ATP2B4 | 2.55e-04 | 719 | 180 | 17 | int:EPHA2 |
| Interaction | STX7 interactions | TTYH1 RALGAPA1 DENND5B EHBP1 VMP1 DENND4A ITSN1 VPS50 SLC39A10 EPN2 RABL6 PTPN14 RAB7A SENP2 ATP2B1 EIF2AK3 | 2.90e-04 | 659 | 180 | 16 | int:STX7 |
| Interaction | PTPRG interactions | 3.09e-04 | 102 | 180 | 6 | int:PTPRG | |
| Interaction | PPFIA2 interactions | 3.23e-04 | 37 | 180 | 4 | int:PPFIA2 | |
| Interaction | IRS1 interactions | 3.31e-04 | 145 | 180 | 7 | int:IRS1 | |
| Interaction | PRKAG2 interactions | 3.56e-04 | 68 | 180 | 5 | int:PRKAG2 | |
| Interaction | ZSCAN5A interactions | 3.58e-04 | 38 | 180 | 4 | int:ZSCAN5A | |
| Interaction | OPTC interactions | 3.60e-04 | 16 | 180 | 3 | int:OPTC | |
| Interaction | UNC13A interactions | 3.60e-04 | 16 | 180 | 3 | int:UNC13A | |
| Interaction | CANX interactions | EHBP1 DNAH3 ABCA2 DTYMK MIS18A TMEM161B ESRRB TMED5 SPTLC1 ST3GAL1 SLC39A10 PCYOX1L PTPRA PTPRE PTPRO UGGT2 SENP2 IL17RA CAMSAP1 ATP1B3 ATP2B1 EIF2AK3 ATP2B3 ATP2B4 | 3.70e-04 | 1261 | 180 | 24 | int:CANX |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p13 | 8.83e-05 | 346 | 185 | 8 | chr17p13 | |
| Cytoband | 17p13.1 | 1.22e-04 | 118 | 185 | 5 | 17p13.1 | |
| Cytoband | 11p14.2 | 3.35e-04 | 7 | 185 | 2 | 11p14.2 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 9.03e-11 | 21 | 130 | 7 | 813 | |
| GeneFamily | Myosin heavy chains | 5.84e-10 | 15 | 130 | 6 | 1098 | |
| GeneFamily | ATPases Ca2+ transporting | 3.13e-07 | 9 | 130 | 4 | 1209 | |
| GeneFamily | Fibronectin type III domain containing | 2.35e-06 | 160 | 130 | 9 | 555 | |
| GeneFamily | Dyneins, axonemal | 2.29e-04 | 17 | 130 | 3 | 536 | |
| GeneFamily | Nuclear hormone receptors | 4.21e-04 | 49 | 130 | 4 | 71 | |
| GeneFamily | Ubiquitin protein ligase E3 component n-recognins | 1.05e-03 | 7 | 130 | 2 | 785 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.09e-03 | 161 | 130 | 6 | 593 | |
| GeneFamily | Anoctamins | 2.22e-03 | 10 | 130 | 2 | 865 | |
| GeneFamily | ATP binding cassette subfamily A | 4.41e-03 | 14 | 130 | 2 | 805 | |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_DN | 1.07e-05 | 20 | 185 | 4 | M1123 | |
| Coexpression | CAMP_UP.V1_DN | RALGAPA1 ANXA1 ITSN1 PCYOX1L PTPRC STXBP1 PTPRD ATP2B1 ATP2B4 | 1.27e-05 | 199 | 185 | 9 | M2719 |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_DN | 1.31e-05 | 21 | 185 | 4 | MM1102 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | RALGAPA1 UBR1 DENND4A ERAP1 ANXA1 SYNE1 TMED5 RANBP9 MR1 YTHDC2 ST3GAL1 TNRC6C DHX9 PTPN7 PTPRA PTPRC PTPRE UBR5 ERAP2 MICB PDS5A AKAP10 IL17RA ATP1B3 OGA ATP2B4 | 1.91e-05 | 1492 | 185 | 26 | M40023 |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.57e-10 | 189 | 185 | 11 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | RA-01._Fibroblast_I|World / Chamber and Cluster_Paper | MYH4 MYH13 CLSTN2 ABCA6 PTPRS CCDC138 UGGT2 ATP1B3 ANO3 PDZRN4 | 4.76e-09 | 181 | 185 | 10 | 2b6ddeb53a79a658e2ba78527ff48c155b20daa6 |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.52e-08 | 185 | 185 | 9 | e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3 | |
| ToppCell | RA|World / Chamber and Cluster_Paper | 1.28e-07 | 194 | 185 | 9 | 08f0afbb68a63150fbe107a5337299081c3f69e4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.65e-07 | 165 | 185 | 8 | dc570154baed59ed109e5369589448e075ba66a9 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.26e-07 | 175 | 185 | 8 | 795a6564d5a75ffd35d39f5274b9e8d28708bbc8 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a7-Tac2-Excitatory_Neuron.Slc17a7.Tac2.Syt15_(Medial_habenula)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 8.29e-07 | 77 | 185 | 6 | 7f624e9262bd0dc2ac4176f43c91a4bc0f521fe5 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.02e-06 | 183 | 185 | 8 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-06 | 184 | 185 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-06 | 184 | 185 | 8 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-06 | 184 | 185 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.06e-06 | 184 | 185 | 8 | ca35a3d2b536c8b2bf5c4d635605e5a3ae94a428 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-06 | 184 | 185 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_EGR3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.15e-06 | 186 | 185 | 8 | 77b09af860183606a1775eba921e2071e4a7dd4e | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-06 | 191 | 185 | 8 | 48823a97c38263f2c6e58348214f5b62773a6368 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-06 | 191 | 185 | 8 | 0eedc66e967b1837ce2c14f8c14b3c1eba868c76 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.40e-06 | 191 | 185 | 8 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.40e-06 | 191 | 185 | 8 | b133ee1c0e58d00ddd2e4e05b01fd04947524c18 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN_to_DP_transition_(most_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-06 | 193 | 185 | 8 | a6a864644e1b80b7417ea0a27281e79068a3fd3d | |
| ToppCell | LA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 1.57e-06 | 194 | 185 | 8 | 803fa83ceada17c38ca9f933b888f7e7b0b90761 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-06 | 194 | 185 | 8 | c49f72441b3557e2c3a9c4239e68c0cf0652814b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-06 | 195 | 185 | 8 | 3c3703f092b6fc1b7333426fb5e2823bfb74bb57 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.70e-06 | 196 | 185 | 8 | 1522958a92e0126326a9f0d9fb1c5b5c50b001ea | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.70e-06 | 196 | 185 | 8 | 1c8294014713684b50885e638668f2ce75f357f0 | |
| ToppCell | RA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.70e-06 | 196 | 185 | 8 | e8cbda03837f1f26470a9d93aa7fdaa04e08e38a | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.77e-06 | 197 | 185 | 8 | 6d0d68d460243a0259ada93ebda40fa7b3088eeb | |
| ToppCell | PND07-Immune-Immune_Myeloid-DC-cDC2-cDC2_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.42e-06 | 144 | 185 | 7 | f5d0d0564fcbec8a5d87119e0807b619faa77b0f | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Ptgdr|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.42e-06 | 144 | 185 | 7 | 71107275767a0728541a3695715c44874b3e5efc | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Fibin|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.30e-06 | 157 | 185 | 7 | 741d79c10cb87fa7f14080c6fccb1553c3a20bad | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(Neuron.Gad1Gad2.Sst-Nr2f2)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.96e-06 | 62 | 185 | 5 | 9db88da996b9977f5a89afe505cd55e7b5324bc9 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(MGE-derived_cortical_interneurons--Martinotti_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.96e-06 | 62 | 185 | 5 | a20620a8869721ea62984c2022ee1b484b455824 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(MGE-derived_cortical_interneurons--Martinotti_cells)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.96e-06 | 62 | 185 | 5 | ee694c06bcd924b4ddf744178ba3a99e04eed51b | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(Neuron.Gad1Gad2.Sst-Nr2f2)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.96e-06 | 62 | 185 | 5 | 461d280a1b955033186cfc326f9ace85b4a53c54 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.25e-06 | 170 | 185 | 7 | 14aa86a4f526ed6986afcb28c49225522055550c | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.25e-06 | 170 | 185 | 7 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Grp_(Neuron.Slc17a6.Grp)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.53e-06 | 65 | 185 | 5 | b7bc23af54d6d2f7afd584f4df42c24d7c49e344 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Grp_(Neuron.Slc17a6.Grp)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.53e-06 | 65 | 185 | 5 | 3b3630253f5713c4a688c74c4ea0f98c1fe42594 | |
| ToppCell | CTRL-Myeloid-Monocyte|Myeloid / Disease state, Lineage and Cell class | 7.53e-06 | 171 | 185 | 7 | bfa01571516a0b24476ae06cb07f56c5579dbd70 | |
| ToppCell | droplet-Pancreas-Exocrine-21m-Epithelial-pancreatic_ductal_cel|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.82e-06 | 172 | 185 | 7 | c0bda7153e02bee7d0326138cc684151c404c2a1 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.01e-05 | 179 | 185 | 7 | 1ac79c82c52fa95bb4e170ab20fec0f648db2134 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-05 | 182 | 185 | 7 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.17e-05 | 183 | 185 | 7 | 8a799807fbf24456a9811e0c64068187940a2f71 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.21e-05 | 184 | 185 | 7 | 689a8af81a79a4bb3123cfa01958c953eab5de98 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.21e-05 | 184 | 185 | 7 | 102b6f621a5b551e622f97b12d787c080b052a72 | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-05 | 185 | 185 | 7 | bb5a4cf93534b9bcd0923f314c389d571e91e7f8 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.30e-05 | 186 | 185 | 7 | bdc87e4631a8ea73e262e541aa84a28f24c94b00 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Ptgdr|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.39e-05 | 125 | 185 | 6 | d05556ea185c15815a4f8643f1c01185badbeece | |
| ToppCell | droplet-Lung-nan-18m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-05 | 188 | 185 | 7 | a6ed43fdd42d681c9fbb2fb368947ab7e41d8d7c | |
| ToppCell | droplet-Lung-nan-18m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-05 | 188 | 185 | 7 | 54550313db78b3b5b572fa1e67092c8f6f33aab5 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.39e-05 | 188 | 185 | 7 | 3177b2c1723268d330d3e9f24f9e24492ace6286 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.39e-05 | 188 | 185 | 7 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | LV-14._Fibroblast_III|World / Chamber and Cluster_Paper | 1.44e-05 | 189 | 185 | 7 | 3922135d1f6fc768d71ba3b465585fead6ea68a8 | |
| ToppCell | IPF-Myeloid-cMonocyte|IPF / Disease state, Lineage and Cell class | 1.49e-05 | 190 | 185 | 7 | a099f51f2b7618b6712af38eedd5ee64d8663a4a | |
| ToppCell | facs-Lung-3m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.49e-05 | 190 | 185 | 7 | 26e2237f65cb43723c5da853831b40df2982d6e4 | |
| ToppCell | droplet-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.49e-05 | 190 | 185 | 7 | e80d66ba0d5c263e94c1ab0b89d1dc7b837af3e1 | |
| ToppCell | droplet-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.49e-05 | 190 | 185 | 7 | f32d66c0e74e0a2a23ecb857c4daf0d8573a806c | |
| ToppCell | droplet-Lung-18m-Endothelial-lymphatic_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.49e-05 | 190 | 185 | 7 | b79ffd05806244a9790cd04c66fb4f92c824e69f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-05 | 190 | 185 | 7 | 562ee3b025c29edf07b8b344323edb49d82f1c7e | |
| ToppCell | facs-Lung-3m-Endothelial-lymphatic_endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.49e-05 | 190 | 185 | 7 | a1514d2186eb4fe569971ab22dc0c17d353fb94a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-05 | 190 | 185 | 7 | f5fb989afabb49d64d91324570cd8c80a4b9e67d | |
| ToppCell | facs-Lung-3m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.49e-05 | 190 | 185 | 7 | 0bb954a94317cfc742b9b6221bb80f8baa6d3ff1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-05 | 191 | 185 | 7 | a6c57627077fa980b7ec1d3894b5f31bfb11b738 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.55e-05 | 191 | 185 | 7 | 08042952431ca1a6fd7dfc13f36eb28643979598 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-05 | 191 | 185 | 7 | 8f6d592edc32fdb901af30501d4360512334e8c2 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD4_INF-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.60e-05 | 192 | 185 | 7 | 1b0138fd0bfdee266325751f8b2d163d91a71bf5 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.60e-05 | 192 | 185 | 7 | b9e4585bea280ca0ae159f0c6a2bf7b88a15a6e6 | |
| ToppCell | LA-14._Fibroblast_III|LA / Chamber and Cluster_Paper | 1.65e-05 | 193 | 185 | 7 | 7426c291bac59e539c427bcaae18abc7d397d44e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.71e-05 | 194 | 185 | 7 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-05 | 195 | 185 | 7 | 79114b3c78cc15c413bb58f0673e7215b784a9b6 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.77e-05 | 195 | 185 | 7 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.83e-05 | 196 | 185 | 7 | a31e227de2dc077b81881295b012d22fedbd65ed | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.83e-05 | 196 | 185 | 7 | b04ca69b0ed44e09c989b575f747e1e819cd8008 | |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 1.95e-05 | 198 | 185 | 7 | bd11b0e9e80449aab979a02c1023e0638c431c7c | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-Mesenchymal-Cilia-bearing_cell|1m / Sample Type, Dataset, Time_group, and Cell type. | 2.01e-05 | 199 | 185 | 7 | fd91fdc76decd5876d5e914d68134282aba9c4c8 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.01e-05 | 199 | 185 | 7 | 6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c | |
| ToppCell | Neuronal-Excitatory-eF(C1QL3)----L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.08e-05 | 200 | 185 | 7 | 44f0278cb0e4ffcda4af3719d7f5819a10929b9f | |
| ToppCell | Neuronal-Excitatory-eF(C1QL3)---|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.08e-05 | 200 | 185 | 7 | 23da7790e09575b2ca909ed16806b44223bf1017 | |
| ToppCell | Neuronal-Excitatory-eF(C1QL3)-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.08e-05 | 200 | 185 | 7 | 91f3df1c5a661ff703835f58a35cee93f18eb15c | |
| ToppCell | Neuronal-Excitatory-eF(C1QL3)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.08e-05 | 200 | 185 | 7 | 7668ae7ed550583ab59e419c5c9bb9f2d7e8e0d5 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.08e-05 | 200 | 185 | 7 | 87827041663013f5e7273168dc8709d69840e7ce | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Mesoderm|6m / Sample Type, Dataset, Time_group, and Cell type. | 2.08e-05 | 200 | 185 | 7 | 0f6851baf0cf2a8b0c95a7a585c4407c330c5f6c | |
| ToppCell | Neuronal-Excitatory-eF(C1QL3)--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.08e-05 | 200 | 185 | 7 | 2e2b1d252972b702ade25526ec8461bf613d81b0 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Glra3|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.48e-05 | 147 | 185 | 6 | 50e86860a94be103092c40e39a172eac92372f0d | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.76e-05 | 149 | 185 | 6 | 48fca6ae33d7722c024b43ce04f4dbce7b6b424b | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.86e-05 | 156 | 185 | 6 | 6365b69ede98bc866e996bc52736b00401aacf6f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.03e-05 | 157 | 185 | 6 | bfec34182f052cf1c0d847ba53ea335d4d1190de | |
| ToppCell | E16.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.59e-05 | 160 | 185 | 6 | b2d8940ea8c068273b7da1589d3d6ae5110d8209 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.59e-05 | 160 | 185 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.59e-05 | 160 | 185 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | E16.5-Immune-Immune_Lymphocytic_T/NK|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.59e-05 | 160 | 185 | 6 | 229841be7b984a00a301cd5d88c11226a90d8a88 | |
| ToppCell | E16.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.59e-05 | 160 | 185 | 6 | 99c9ae2041445539fada842e1af01368669bfca0 | |
| ToppCell | COVID-19-kidney-Epithelial_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 5.59e-05 | 160 | 185 | 6 | 0d4880f85565d8c540c94a8f8109147b3029279a | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Glra3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.59e-05 | 160 | 185 | 6 | 0bfdaf979e6f128cba2928ce16bca4d3deff8ac9 | |
| ToppCell | E16.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.59e-05 | 160 | 185 | 6 | 9caab1bb63c7e66c44783852ee75b16bb40fa594 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 5.79e-05 | 161 | 185 | 6 | 347edb0de10850b7d16c40945751033289289c9b | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.99e-05 | 162 | 185 | 6 | 8a488ecd25ef41468c3c7766eb936dbc2f7665a9 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Papillary_Carcinoma-8|TCGA-Breast / Sample_Type by Project: Shred V9 | 6.72e-05 | 102 | 185 | 5 | 631b22bd588e5259873b4253435a6e6b3cced346 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.86e-05 | 166 | 185 | 6 | 6e6075d0c913e2516083f6dcab21d5878bcef7a4 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-plasmacytoid_dendritic_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.86e-05 | 166 | 185 | 6 | 1ca888ae8168707493f19ee52a89d7c70e6cb51d | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.86e-05 | 166 | 185 | 6 | 4fbe44e0aea197893614cd55f83119aa0f73ee53 | |
| Drug | B0683 | 2.77e-09 | 117 | 183 | 11 | CID006398969 | |
| Drug | fast white | 4.11e-08 | 42 | 183 | 7 | CID000024008 | |
| Drug | trifluoperazine | MYH1 MYH2 LPAR3 MYH4 MYH6 MYH8 MYH13 ANXA1 ITGA9 CHRNA2 PRKCI ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 6.14e-08 | 324 | 183 | 15 | CID000005566 |
| Drug | chlordecone | 6.50e-08 | 67 | 183 | 8 | CID000000299 | |
| Drug | verapamil | BOC MYH1 MYH2 MYH4 MYH6 MYH8 ABCA2 MYH13 KCNK16 PKD1L3 CHRNA2 ABCA6 PRKCI ATP1B3 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 9.55e-08 | 490 | 183 | 18 | CID000002520 |
| Drug | TAT-59 | 1.29e-07 | 16 | 183 | 5 | CID003034829 | |
| Drug | 2-(oxalylamino)benzoic acid | 1.39e-07 | 7 | 183 | 4 | ctd:C405943 | |
| Drug | clenbuterol | 2.34e-07 | 142 | 183 | 10 | CID000002783 | |
| Drug | nifedipine | MYH1 MYH2 MYH4 MYH6 MYH8 MYH13 SGCD PKD1L3 FADS2 PRKCI ATP2B1 ATP2B2 EIF2AK3 ATP2B3 ATP2B4 SOD3 | 2.68e-07 | 415 | 183 | 16 | CID000004485 |
| Drug | toxaphene | 4.11e-07 | 58 | 183 | 7 | CID005284469 | |
| Drug | U23,469 | 4.93e-07 | 9 | 183 | 4 | CID000161922 | |
| Drug | fadrozole | 7.60e-07 | 40 | 183 | 6 | CID000059693 | |
| Drug | 1sqc | 8.17e-07 | 10 | 183 | 4 | CID000444279 | |
| Drug | strontium | 1.24e-06 | 68 | 183 | 7 | CID000104798 | |
| Drug | 2,5-dimethylquinone | 1.28e-06 | 11 | 183 | 4 | CID000008718 | |
| Drug | AC1NRBPQ | 1.70e-06 | 137 | 183 | 9 | CID005288569 | |
| Drug | 1vyq | 1.90e-06 | 12 | 183 | 4 | CID004369390 | |
| Drug | Ro 46861 | 1.90e-06 | 12 | 183 | 4 | CID000003128 | |
| Drug | ketononestrol aziridine | 2.73e-06 | 13 | 183 | 4 | CID000130642 | |
| Drug | 8-hydroxycoumarin | 2.73e-06 | 13 | 183 | 4 | CID000122783 | |
| Drug | formycin triphosphate | 3.31e-06 | 51 | 183 | 6 | CID000122274 | |
| Drug | K-Cl | MYH1 MYH2 MYH4 MYH6 MYH8 MYH13 ESRRA ESRRB ESRRG KCNK16 PGR GHRH ATP1B3 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 3.57e-06 | 567 | 183 | 17 | CID000004873 |
| Drug | p-hydroxyhippuric acid | 3.80e-06 | 14 | 183 | 4 | CID000151012 | |
| Drug | blebbistatin | 4.53e-06 | 116 | 183 | 8 | CID003476986 | |
| Drug | NSC9700 | BOC MYH1 MYH2 MYH4 MYH6 MYH8 MYH13 ESRRA TRPC3 ESRRB ESRRG TTPA PGR GHRH SERPINB3 SERPINB4 PRKCI | 4.60e-06 | 578 | 183 | 17 | CID000005408 |
| Drug | Methylhydantoin-5-(D) [55147-68-7]; Up 200; 35uM; HL60; HT_HG-U133A | 4.84e-06 | 198 | 183 | 10 | 2994_UP | |
| Drug | oxovanadium | 5.83e-06 | 120 | 183 | 8 | CID000024411 | |
| Drug | SM-2 | 6.57e-06 | 87 | 183 | 7 | CID000486033 | |
| Drug | OH-PCB 30 | 6.82e-06 | 16 | 183 | 4 | CID000105036 | |
| Drug | purealin | 7.11e-06 | 58 | 183 | 6 | CID006419303 | |
| Drug | centchroman | 7.31e-06 | 34 | 183 | 5 | CID000035805 | |
| Drug | thiirane | 8.86e-06 | 17 | 183 | 4 | CID000009865 | |
| Drug | AC1L88YH | 8.86e-06 | 17 | 183 | 4 | CID000374551 | |
| Drug | nsc25485 | BOC LPAR3 PKD1L3 SERPINB3 SERPINB4 PRKCI ATP1B3 ATP2B1 ATP2B2 ATP2B3 ATP2B4 PLCE1 | 8.98e-06 | 312 | 183 | 12 | CID000004605 |
| Drug | molybdate | 9.40e-06 | 128 | 183 | 8 | CID000024621 | |
| Drug | anastrozole | 1.12e-05 | 37 | 183 | 5 | CID000002187 | |
| Drug | tBuBHQ | 1.96e-05 | 69 | 183 | 6 | CID000002374 | |
| Drug | 4-epidoxorubicin | MYH1 MYH2 MYH4 MYH6 MYH8 MYH13 ESRRA ESRRB ESRRG BCL2L1 TTPA PGR CSF3 MTOR SERPINB3 SERPINB4 PRKCI EPN1 SOD3 | 2.09e-05 | 788 | 183 | 19 | CID000001690 |
| Drug | AC1NDP1R | 2.12e-05 | 42 | 183 | 5 | CID004629338 | |
| Drug | 2brh | 2.17e-05 | 21 | 183 | 4 | CID000848641 | |
| Drug | AC1L2JTN | 2.17e-05 | 21 | 183 | 4 | CID000022150 | |
| Drug | indenestrol A | 2.17e-05 | 21 | 183 | 4 | CID000107664 | |
| Drug | cuprizone | 2.50e-05 | 72 | 183 | 6 | CID000009723 | |
| Drug | indenestrol B | 2.64e-05 | 22 | 183 | 4 | CID000114716 | |
| Drug | lasofoxifene | 2.67e-05 | 44 | 183 | 5 | CID000216416 | |
| Drug | yohimbine; Up 200; 22.9uM; MCF7; HT_HG-U133A_EA | 2.86e-05 | 194 | 183 | 9 | 1119_UP | |
| Drug | p-nitrophenyl phosphate | 2.86e-05 | 194 | 183 | 9 | CID000000378 | |
| Drug | D-triiodothyronine | MYH1 MYH2 MYH4 MYH6 MYH8 MYH13 GHRH NCOR2 PRKCI ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 2.86e-05 | 409 | 183 | 13 | CID000000861 |
| Drug | MgCl2 | MYH1 MYH2 MYH4 MYH6 MYH8 MYH13 FADS2 OGA ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 3.13e-05 | 354 | 183 | 12 | CID000024584 |
| Drug | AC1L25Y6 | 3.17e-05 | 23 | 183 | 4 | CID000015465 | |
| Drug | lanthanum chloride hydrate | 3.17e-05 | 23 | 183 | 4 | CID000165791 | |
| Drug | triphenylethylene | 3.33e-05 | 46 | 183 | 5 | CID000006025 | |
| Drug | 4-chloroaniline | 3.92e-05 | 202 | 183 | 9 | CID000007812 | |
| Drug | carbachol | MYH1 MYH2 MYH4 MYH6 MYH8 TRPC7 MYH13 TRPC3 PKD1L3 CHRNA2 UBXN11 PRKCI ATP2B1 ATP2B2 ATP2B3 ATP2B4 PLCE1 | 4.29e-05 | 688 | 183 | 17 | CID000002551 |
| Drug | cyhexatin | 4.48e-05 | 25 | 183 | 4 | CID005364545 | |
| Drug | C13932 | 4.57e-05 | 206 | 183 | 9 | CID000168297 | |
| Drug | benzoquinone | 5.11e-05 | 209 | 183 | 9 | CID000004650 | |
| Drug | dodecyl ether | 5.26e-05 | 26 | 183 | 4 | CID000020667 | |
| Drug | ORG 2058 | 5.53e-05 | 51 | 183 | 5 | CID000119086 | |
| Drug | N-desmethyl-tamoxifen-hydrochloride | 6.08e-05 | 52 | 183 | 5 | CID000035887 | |
| Drug | idoxifene | 6.13e-05 | 27 | 183 | 4 | CID003034011 | |
| Drug | nafoxidine | 6.13e-05 | 27 | 183 | 4 | CID000004416 | |
| Drug | N'-((1E)-(4-(diethylamino)phenyl)methylene)-4-hydroxybenzohydrazide | 6.43e-05 | 2 | 183 | 2 | ctd:C501618 | |
| Drug | caloxin 1b1 | 6.43e-05 | 2 | 183 | 2 | ctd:C510327 | |
| Drug | Sodium Fluoride | DENND5B IGFN1 SGCD ANXA1 ITSN1 GPRC6A FAM170A CHRNA2 PGR IHO1 GHRH CLEC4F PTPRA CSF3 NALCN ABCA6 PTPRS RAB7A ATP1B3 EIF2AK3 | 6.57e-05 | 933 | 183 | 20 | ctd:D012969 |
| Drug | 17-isoprogesterone | SOX4 UBR1 MYH1 ABCA2 ANXA1 ESRRA ESRRB ESRRG YTHDC2 BCL2L1 TTPA CHRNA2 PGR GHRH SLC22A9 NCOR2 UBR5 SERPINB3 SERPINB4 FADS2 PRKCI SOD3 BMP15 | 6.84e-05 | 1170 | 183 | 23 | CID000004920 |
| Drug | RU 16117 | 7.11e-05 | 28 | 183 | 4 | CID000066408 | |
| Drug | MCDF | 7.11e-05 | 28 | 183 | 4 | CID000114900 | |
| Drug | biochanin A | 7.31e-05 | 87 | 183 | 6 | ctd:C004541 | |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | 7.53e-05 | 171 | 183 | 8 | 7535_DN | |
| Drug | hydroxyl radicals | BOC PDE6A ANXA1 GLB1L TPTE2 CLSTN2 TYK2 PCYOX1L OTC PTPN7 PTPN14 PTPRC PTPRD PTPRE PTPRF PTPRO PTPRS FADS2 PRKCI ATP1B3 ATP2B1 ATP2B2 ATP2B3 ATP2B4 SOD3 | 7.57e-05 | 1341 | 183 | 25 | CID000000961 |
| Drug | benzyl chloride | 8.04e-05 | 11 | 183 | 3 | CID000007503 | |
| Drug | CDRI-85/287 | 8.20e-05 | 29 | 183 | 4 | CID000159508 | |
| Drug | Tl-I | 8.20e-05 | 29 | 183 | 4 | CID006432721 | |
| Drug | LY117018 | 8.20e-05 | 29 | 183 | 4 | CID000104946 | |
| Drug | octaethylene glycol | 8.20e-05 | 29 | 183 | 4 | CID000078798 | |
| Drug | AC1LADJ6 | 8.89e-05 | 130 | 183 | 7 | CID000486032 | |
| Drug | AC1L9KAY | 9.40e-05 | 30 | 183 | 4 | CID000446966 | |
| Drug | AC1NSKPI | 9.48e-05 | 57 | 183 | 5 | CID005311482 | |
| Drug | ethylketocyclazocine | 1.03e-04 | 58 | 183 | 5 | CID000135018 | |
| Drug | lanthanum | 1.18e-04 | 136 | 183 | 7 | CID000023926 | |
| Drug | sanguinarine | 1.21e-04 | 60 | 183 | 5 | CID000005154 | |
| Drug | butyl benzyl phthalate | 1.22e-04 | 32 | 183 | 4 | CID000002347 | |
| Drug | o,p'-DDE | 1.22e-04 | 32 | 183 | 4 | CID000246598 | |
| Drug | AC1L1GHE | 1.26e-04 | 96 | 183 | 6 | CID000003684 | |
| Drug | phenol red | 1.31e-04 | 61 | 183 | 5 | CID000004766 | |
| Drug | 2-phenylindole | 1.38e-04 | 13 | 183 | 3 | CID000013698 | |
| Drug | RU 58668 | 1.38e-04 | 33 | 183 | 4 | CID000119604 | |
| Drug | mannan | 1.53e-04 | 63 | 183 | 5 | CID000000870 | |
| Drug | AC1L1K7W | 1.55e-04 | 34 | 183 | 4 | CID000005377 | |
| Drug | formononetin | 1.55e-04 | 34 | 183 | 4 | CID005280378 | |
| Drug | Fenoprofen calcium salt dihydrate [53746-45-5]; Up 200; 7.2uM; PC3; HT_HG-U133A | 1.56e-04 | 190 | 183 | 8 | 4274_UP | |
| Drug | S-(-)-Etomoxir | 1.58e-04 | 100 | 183 | 6 | CID000060765 | |
| Drug | fluorescamine | 1.74e-04 | 35 | 183 | 4 | CID000037927 | |
| Drug | dihydropyridine | 1.74e-04 | 193 | 183 | 8 | CID000104822 | |
| Drug | Hymecromone [90-33-5]; Down 200; 22.8uM; PC3; HT_HG-U133A | 1.74e-04 | 193 | 183 | 8 | 4623_DN | |
| Drug | Graveoline [485-61-0]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 1.80e-04 | 194 | 183 | 8 | 4738_DN | |
| Drug | Hexylcaine hydrochloride [532-76-3]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 1.80e-04 | 194 | 183 | 8 | 3447_DN | |
| Drug | (-)-Quinpirole hydrochloride [85760-74-3]; Down 200; 15.6uM; MCF7; HT_HG-U133A | 1.80e-04 | 194 | 183 | 8 | 3539_DN | |
| Drug | Aminopurine, 6-benzyl [1214-39-7]; Down 200; 17.8uM; MCF7; HT_HG-U133A | 1.87e-04 | 195 | 183 | 8 | 4748_DN | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 9.75e-12 | 10 | 180 | 6 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 9.75e-12 | 10 | 180 | 6 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 9.75e-12 | 10 | 180 | 6 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 9.75e-12 | 10 | 180 | 6 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 9.75e-12 | 10 | 180 | 6 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 9.75e-12 | 10 | 180 | 6 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 9.75e-12 | 10 | 180 | 6 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 9.75e-12 | 10 | 180 | 6 | DOID:0080326 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 4.25e-11 | 12 | 180 | 6 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 4.25e-11 | 12 | 180 | 6 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 7.85e-11 | 13 | 180 | 6 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 2.27e-10 | 15 | 180 | 6 | DOID:0050646 (implicated_via_orthology) | |
| Disease | cardiomyopathy (implicated_via_orthology) | 1.26e-08 | 71 | 180 | 8 | DOID:0050700 (implicated_via_orthology) | |
| Disease | azoospermia (implicated_via_orthology) | 1.26e-08 | 27 | 180 | 6 | DOID:14227 (implicated_via_orthology) | |
| Disease | myopathy (implicated_via_orthology) | 1.67e-08 | 48 | 180 | 7 | DOID:423 (implicated_via_orthology) | |
| Disease | Hailey-Hailey disease (implicated_via_orthology) | 1.99e-08 | 6 | 180 | 4 | DOID:0050429 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 3.27e-08 | 80 | 180 | 8 | DOID:12930 (implicated_via_orthology) | |
| Disease | Proprioceptive Disorders | 3.70e-05 | 2 | 180 | 2 | C0752260 | |
| Disease | Somatosensory Disorders | 3.70e-05 | 2 | 180 | 2 | C0752262 | |
| Disease | Thermal Sensation Disorders | 3.70e-05 | 2 | 180 | 2 | C0752261 | |
| Disease | Impairment, Light Touch Sensation | 3.70e-05 | 2 | 180 | 2 | C0752255 | |
| Disease | Pinprick Sensation Diminished | 3.70e-05 | 2 | 180 | 2 | C0752257 | |
| Disease | Pain Sensation Diminished | 3.70e-05 | 2 | 180 | 2 | C0752256 | |
| Disease | Position Sense Disorders | 3.70e-05 | 2 | 180 | 2 | C0752258 | |
| Disease | brain aneurysm | 6.98e-05 | 113 | 180 | 6 | EFO_0003870 | |
| Disease | platelet crit | VMP1 DNAH3 MYH13 ERAP1 SLC38A9 BCL2L1 SLFN14 NUP205 TYK2 PTPN7 THADA PTPRC MICB MAD1L1 FADS2 ATP2B4 PLCE1 | 7.94e-05 | 952 | 180 | 17 | EFO_0007985 |
| Disease | Malignant neoplasm of breast | BOC EHBP1 MYH1 SYNE1 ESRRA SPTLC1 DNAJC21 ITGA9 PGR SLC22A9 PTPN14 PTPRC PTPRD CSF3 OTOF MTOR ZFYVE26 DMD | 1.08e-04 | 1074 | 180 | 18 | C0006142 |
| Disease | dilated cardiomyopathy 1L (implicated_via_orthology) | 1.11e-04 | 3 | 180 | 2 | DOID:0110436 (implicated_via_orthology) | |
| Disease | Severe Dengue | 1.11e-04 | 3 | 180 | 2 | C0019100 | |
| Disease | Dengue Shock Syndrome | 1.11e-04 | 3 | 180 | 2 | C0376300 | |
| Disease | attention deficit hyperactivity disorder, mental or behavioural disorder | 1.11e-04 | 3 | 180 | 2 | EFO_0000677, EFO_0003888 | |
| Disease | monocyte count | RALGAPA1 VMP1 DENND4A FGD2 SZT2 SLC38A9 BCL2L1 NCOR2 THADA UBXN11 PTPRA PTPRC CSF3 MICB CES3 RAB7A IL17RA ATP1B3 ATP2B4 PLCE1 | 1.73e-04 | 1320 | 180 | 20 | EFO_0005091 |
| Disease | Hypertensive disease | 1.74e-04 | 190 | 180 | 7 | C0020538 | |
| Disease | waist-hip ratio | MPP2 SLC38A9 SGCD IL20RB YTHDC2 PLXND1 ITGA9 NUP205 WDR38 THADA PTPRD PTPRS DNAH17 ATP1B3 ATP2B4 ANO3 PLCE1 SYMPK PDZRN4 | 1.90e-04 | 1226 | 180 | 19 | EFO_0004343 |
| Disease | frontal fibrosing alopecia | 2.11e-04 | 48 | 180 | 4 | EFO_0009855 | |
| Disease | arthrogryposis multiplex congenita (is_implicated_in) | 2.20e-04 | 4 | 180 | 2 | DOID:0080954 (is_implicated_in) | |
| Disease | Headache, HbA1c measurement | 2.74e-04 | 21 | 180 | 3 | EFO_0004541, HP_0002315 | |
| Disease | muscular dystrophy (implicated_via_orthology) | 2.74e-04 | 21 | 180 | 3 | DOID:9884 (implicated_via_orthology) | |
| Disease | Liver Cirrhosis, Experimental | SOX4 ERAP1 HYKK ANXA1 RTP3 NCOR2 OTC CLEC4F PTPRC PTPRD CSF3 PTPRO CES3 SENP2 | 3.03e-04 | 774 | 180 | 14 | C0023893 |
| Disease | economic and social preference | 3.27e-04 | 97 | 180 | 5 | EFO_0004827 | |
| Disease | leiomyosarcoma | 3.66e-04 | 5 | 180 | 2 | C0023269 | |
| Disease | Leiomyosarcoma, Epithelioid | 3.66e-04 | 5 | 180 | 2 | C0205815 | |
| Disease | Leiomyosarcoma, Myxoid | 3.66e-04 | 5 | 180 | 2 | C0205816 | |
| Disease | forced expiratory volume, response to bronchodilator | 4.31e-04 | 445 | 180 | 10 | EFO_0004314, GO_0097366 | |
| Disease | pallidum volume | 4.65e-04 | 25 | 180 | 3 | EFO_0006933 | |
| Disease | free androgen index | 5.12e-04 | 374 | 180 | 9 | EFO_0007005 | |
| Disease | parenchymal hematoma, response to recombinant tissue-plasminogen activator | 5.46e-04 | 6 | 180 | 2 | EFO_0020101, EFO_0600080 | |
| Disease | brain volume measurement, putamen volume | 5.46e-04 | 6 | 180 | 2 | EFO_0006930, EFO_0006932 | |
| Disease | Bipolar Disorder | ANKK1 TRPC7 SYNE1 TRPC3 ST3GAL1 ITGA9 CHRNA2 FADS2 AKAP10 PRKCI | 7.37e-04 | 477 | 180 | 10 | C0005586 |
| Disease | Dengue Hemorrhagic Fever | 7.62e-04 | 7 | 180 | 2 | EFO_0004227 | |
| Disease | endoplasmic reticulum aminopeptidase 1 measurement | 7.62e-04 | 7 | 180 | 2 | EFO_0008119 | |
| Disease | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | 7.97e-04 | 398 | 180 | 9 | EFO_0003756, EFO_0003888, EFO_0004337 | |
| Disease | physical activity measurement | 7.99e-04 | 245 | 180 | 7 | EFO_0008002 | |
| Disease | NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE | 8.03e-04 | 30 | 180 | 3 | C1868672 | |
| Disease | susceptibility to mononucleosis measurement | 8.50e-04 | 69 | 180 | 4 | EFO_0008403 | |
| Disease | progressive supranuclear palsy | 8.85e-04 | 31 | 180 | 3 | MONDO_0019037 | |
| Disease | severe pre-eclampsia (is_marker_for) | 1.01e-03 | 8 | 180 | 2 | DOID:13129 (is_marker_for) | |
| Disease | mean arterial pressure | CWF19L2 SZT2 ERAP1 ESRRB THADA PTPRD ERAP2 PDS5A ATP2B1 PLCE1 | 1.04e-03 | 499 | 180 | 10 | EFO_0006340 |
| Disease | HOMA-IR | 1.06e-03 | 33 | 180 | 3 | EFO_0004501 | |
| Disease | coronary artery disease | EHBP1 IFT140 CWF19L2 NBEAL1 SGCD PKD1L3 SGCZ THADA PTPRO MICB MAD1L1 FER ATP1B3 MCTP2 ATP2B1 UNC13A PLCE1 | 1.07e-03 | 1194 | 180 | 17 | EFO_0001645 |
| Disease | electroencephalogram measurement | 1.10e-03 | 74 | 180 | 4 | EFO_0004357 | |
| Disease | cognitive function measurement | CFAP95 DENND4A SZT2 TMEM161B ESRRG IL20RB YTHDC2 CLSTN2 PKD1L3 FAM186B SGCZ PTPRD PTPRF MAD1L1 PDS5A DDX53 ATP1B3 OGA MYBPC2 | 1.27e-03 | 1434 | 180 | 19 | EFO_0008354 |
| Disease | Distal arthrogryposis | 1.30e-03 | 9 | 180 | 2 | cv:C0265213 | |
| Disease | cognitive disorder (is_implicated_in) | 1.30e-03 | 9 | 180 | 2 | DOID:1561 (is_implicated_in) | |
| Disease | interferon alpha/beta receptor 1 measurement | 1.30e-03 | 9 | 180 | 2 | EFO_0021850 | |
| Disease | Colorectal Carcinoma | BOC DNAH3 SYNE1 CLSTN2 SLC22A9 NAMPT PTPRD ABCA6 PTPRS FADS2 DMD PDZRN4 | 1.32e-03 | 702 | 180 | 12 | C0009402 |
| Disease | cortical thickness | EHBP1 VMP1 NBEAL1 TMED5 MR1 BCL2L1 PLXND1 VPS13D THADA PTPRF FADS2 AKAP10 ATP1B3 CLUH PLCE1 PDZRN4 | 1.36e-03 | 1113 | 180 | 16 | EFO_0004840 |
| Disease | hemoglobin A1 measurement | SLC38A9 ITSN1 PLXND1 THADA PTPRA MAD1L1 FADS2 ATP2B4 ANO3 KIF1C | 1.41e-03 | 520 | 180 | 10 | EFO_0007629 |
| Disease | cognitive function measurement, self reported educational attainment | 1.58e-03 | 355 | 180 | 8 | EFO_0004784, EFO_0008354 | |
| Disease | brain ischemia (is_implicated_in) | 1.61e-03 | 10 | 180 | 2 | DOID:2316 (is_implicated_in) | |
| Disease | Muscle Weakness | 1.61e-03 | 10 | 180 | 2 | C0151786 | |
| Disease | post-traumatic stress disorder symptom measurement | 1.62e-03 | 82 | 180 | 4 | EFO_0008535 | |
| Disease | sporadic amyotrophic lateral sclerosis | 1.72e-03 | 140 | 180 | 5 | EFO_0001357 | |
| Disease | personality trait | 1.74e-03 | 39 | 180 | 3 | EFO_0004365 | |
| Disease | bipolar I disorder | 1.77e-03 | 141 | 180 | 5 | EFO_0009963 | |
| Disease | Malignant neoplasm of liver | 1.83e-03 | 142 | 180 | 5 | C0345904 | |
| Disease | Liver neoplasms | 1.83e-03 | 142 | 180 | 5 | C0023903 | |
| Disease | attention deficit hyperactivity disorder, conduct disorder | 1.87e-03 | 40 | 180 | 3 | EFO_0003888, EFO_0004216 | |
| Disease | endometrial carcinoma, endometriosis | 1.96e-03 | 11 | 180 | 2 | EFO_0001065, EFO_1001512 | |
| Disease | gastric adenocarcinoma (is_implicated_in) | 1.96e-03 | 11 | 180 | 2 | DOID:3717 (is_implicated_in) | |
| Disease | transient cerebral ischemia (is_implicated_in) | 1.96e-03 | 11 | 180 | 2 | DOID:224 (is_implicated_in) | |
| Disease | phosphatidylcholine 32:0 measurement | 1.96e-03 | 11 | 180 | 2 | EFO_0010372 | |
| Disease | descending aortic diameter | 2.10e-03 | 88 | 180 | 4 | EFO_0021788 | |
| Disease | testosterone measurement | UBR1 NRDE2 MYH2 DENND4A TRPC7 SGCD NICN1 ESRRG DNAH2 TYK2 GRAMD1B NCOR2 THADA PTPRF SUSD1 ATP2B2 ATP2B4 | 2.15e-03 | 1275 | 180 | 17 | EFO_0004908 |
| Disease | tuberculosis | 2.17e-03 | 216 | 180 | 6 | MONDO_0018076 | |
| Disease | BMI-adjusted waist-hip ratio, sex interaction measurement | 2.30e-03 | 43 | 180 | 3 | EFO_0007788, EFO_0008343 | |
| Disease | nicotine dependence (implicated_via_orthology) | 2.35e-03 | 12 | 180 | 2 | DOID:0050742 (implicated_via_orthology) | |
| Disease | vitamin supplement exposure measurement, cleft lip | 2.35e-03 | 12 | 180 | 2 | EFO_0003959, EFO_0009116 | |
| Disease | QRS duration | 2.44e-03 | 298 | 180 | 7 | EFO_0005055 | |
| Disease | Familial dilated cardiomyopathy | 2.46e-03 | 44 | 180 | 3 | C0340427 | |
| Disease | neuroticism measurement, cognitive function measurement | NBEAL1 SGCD ESRRG PKD1L3 SGCZ PTPRO MAD1L1 AKAP10 OGA MYBPC2 | 2.61e-03 | 566 | 180 | 10 | EFO_0007660, EFO_0008354 |
| Disease | Modic type vertebral endplate changes | 2.76e-03 | 13 | 180 | 2 | HP_0030775 | |
| Disease | RS-10-hydroxywarfarin measurement | 3.10e-03 | 98 | 180 | 4 | EFO_0803330 | |
| Disease | Cardiomyopathy, Dilated | 3.16e-03 | 48 | 180 | 3 | C0007193 | |
| Disease | precuneus cortex volume measurement | 3.21e-03 | 14 | 180 | 2 | EFO_0010326 | |
| Disease | epilepsy (implicated_via_orthology) | 3.32e-03 | 163 | 180 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | Cardiomyopathy, Familial Idiopathic | 3.54e-03 | 50 | 180 | 3 | C1449563 | |
| Disease | delta-6 desaturase measurement | 3.69e-03 | 15 | 180 | 2 | EFO_0007765 | |
| Disease | P wave duration | 3.69e-03 | 15 | 180 | 2 | EFO_0005094 | |
| Disease | Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive | 3.75e-03 | 51 | 180 | 3 | cv:CN043650 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KISAEVMWNLFAQDM | 1081 | Q9UPW8 | |
| AKQSKWLVIVMTVMS | 236 | Q9H313 | |
| MDIVIKVSVADWKVM | 306 | Q9NZJ5 | |
| WKIAKMIVSDIMQQA | 636 | O43572 | |
| LSKWMEQSTRMQYIE | 166 | Q8NFD2 | |
| VENIMYAMLNEKIDW | 871 | Q8N139 | |
| IDVDEKNQMMTTNVW | 96 | Q15822 | |
| DKEMQVLVSRIAAWM | 156 | Q07817 | |
| QEWKSIVLDMATKMT | 396 | Q6RI45 | |
| SMVTMFPKLQLEWNV | 781 | Q8IYM0 | |
| MRKEMNVLTEWLAAT | 1576 | P11532 | |
| GIIMVLKQTWNNFME | 651 | Q32M45 | |
| VPKNLTDQFTITMWM | 371 | Q9H4D0 | |
| EDAMVFWINKVNLKM | 186 | Q5T5Y3 | |
| QMLWVNLIMDTLASL | 886 | P20020 | |
| KAVQMLWVNLIMDTF | 906 | Q01814 | |
| AVQMLWVNLIMDTFA | 881 | Q16720 | |
| KAVQMLWVNLIMDTF | 871 | P23634 | |
| WREIIKSSVMLLDQM | 696 | Q3KR37 | |
| GVIMFLKQIWNNFME | 696 | Q9BYT9 | |
| EDSKYVLIQMLWDNM | 1711 | Q7Z401 | |
| VNSNMWTEKLLEDMM | 1536 | Q6ZS30 | |
| KSLLFDAMNMTWTVI | 146 | Q8TD07 | |
| REGEWQTMIQKMVSS | 361 | Q96S59 | |
| IDNMEMKVNVPRWTV | 161 | Q6ZS82 | |
| KKILDNWMTIQELMT | 1001 | Q6ZMN7 | |
| SCSDTWVIEQMVILM | 186 | Q9NZP2 | |
| VLVSWIMSVLNSMLQ | 146 | Q8NGA2 | |
| LWFMLEVLMTKNENN | 1031 | Q29RF7 | |
| MVDDRLVTMQIWDTA | 51 | P51149 | |
| NGVVMMFDITKQWTF | 141 | Q3YEC7 | |
| DTMQVMKWFQTALTR | 296 | Q8IWB1 | |
| EMVWQEEVSLIVMLT | 181 | P35236 | |
| NQMSWLMKTASIELR | 1111 | Q92621 | |
| MAMVSEFLKQAWFIE | 1 | P04083 | |
| KLSQMCLNTEWVEMK | 96 | Q5VTT2 | |
| YQIIMTMIVHKNWVD | 281 | O95864 | |
| RQVMNMWSEQEKETF | 426 | Q9Y618 | |
| MTWVGRQKQEMVESN | 426 | Q96F46 | |
| MVWEQKSATIVMLTN | 221 | P23469 | |
| FFRNVDWDMMEQKQV | 521 | P41743 | |
| SIRDILSWVNFMNKM | 1601 | Q9NU22 | |
| RITMAIWNTMQFLKS | 666 | Q6DN12 | |
| ISELQWSVMDQEMRV | 166 | Q9Y6D9 | |
| MNFNVWNIKEMLSIP | 1 | Q8IYA8 | |
| LDQWAMEQFVQVIME | 61 | Q96T55 | |
| MEQFVQVIMEAWVKG | 66 | Q96T55 | |
| VAFSEIMSMVWKRLN | 51 | O95208 | |
| WTANMEQIMKAQALR | 471 | Q58FF7 | |
| VEKSVNEVMEWMNNV | 751 | Q92598 | |
| LMSNAWKEMDITQLV | 176 | O95972 | |
| QWIVTVQKACMVFQM | 511 | O95786 | |
| DVKTMMNTWTLQKGF | 516 | Q9NZ08 | |
| EKMFLWMVTRINQQL | 436 | P13535 | |
| FLRLQMWVEEVMEKF | 141 | Q8NBM8 | |
| TESVVEKMLTNWMSI | 1486 | Q9Y4D7 | |
| QMMEFLLVRFTENWV | 6 | Q8NGZ2 | |
| EAENRKWTIMAVMVS | 326 | P00480 | |
| EKMFLWMVARINQQL | 436 | Q9UKX2 | |
| EWTQYMMLEQTRKEI | 696 | P16499 | |
| TQIIKRDEWMTVDFM | 146 | Q2TBE0 | |
| DKIGMEIMSYQIWVD | 131 | Q12996 | |
| WLVMVSIIAMGNTLQ | 11 | Q9UKR5 | |
| QTVNKLWMVLNTVMP | 811 | Q9H0H0 | |
| QLWMAFVAFQDEVMK | 326 | Q9H7Z3 | |
| WATMADLKMQAVKEI | 741 | O43896 | |
| WTVSNLMAFLIMVVV | 191 | Q9UBY5 | |
| IMMLEHTQKVQNDWL | 546 | Q6ZN66 | |
| DKMFLWMVTRINQQL | 436 | P12882 | |
| LAMNVTNFWKEDAMK | 161 | Q29980 | |
| RSLAKVIMVLWFMQQ | 46 | Q14168 | |
| QSWMTMANLEKELQE | 256 | Q5F1R6 | |
| LTMNKKTWEQMLQIL | 556 | Q2PPJ7 | |
| MQTFTMVLEEIWTSL | 1 | Q6UXL0 | |
| MVSYKEMLDTVRQQW | 261 | Q9NZB8 | |
| KMDLGKIEFTWQEVM | 1581 | Q7Z442 | |
| FWKMVLQQKSQIIVM | 1021 | Q16827 | |
| RMLWENNSTIVVMLT | 1766 | Q13332 | |
| LFNKAIEMNINKMWI | 286 | Q5T6X5 | |
| DQITLIQYSWMSLMV | 746 | P06401 | |
| LFFINMWQKEEMGIS | 681 | Q13797 | |
| QQMFDMGQKAVEEIW | 346 | A2RU49 | |
| TDAVNETTIMLKWMY | 721 | Q9BWV1 | |
| LMTEQLQWMPFVNIK | 406 | Q96M89 | |
| FLTAIMQSMARKNEW | 4331 | Q9UFH2 | |
| SDLRISMWQIQMFLN | 3701 | Q8TD57 | |
| MWNNLTAESLQVMLK | 296 | P16591 | |
| DQMSLLQSAWMEILI | 296 | P62508 | |
| KEVAMIFVNWKELIM | 1276 | Q15811 | |
| QTILTQWMMFPLKID | 501 | Q6UWU2 | |
| GQTLMINQLIDMEWK | 126 | Q86VX2 | |
| MFATFIDNKIMSQWE | 566 | Q6ZUT9 | |
| WIQDMMERAIIDTFV | 661 | Q9BZC7 | |
| MQEWFMLVNKKNALI | 1116 | Q8NDI1 | |
| FATTIWQQMEELGMA | 146 | P09919 | |
| NAEVKEMMTTWTLQK | 531 | Q6P179 | |
| VAFSEIMSMIWKRLN | 51 | Q9Y6I3 | |
| MISWMQAFQAAIDQI | 406 | Q7Z6J4 | |
| SCMSEMQVINWRKEN | 186 | Q86TM3 | |
| KMDLEQIWQLLMTAD | 161 | Q86VF2 | |
| LQEEMTWMKEILSNL | 286 | Q9HBU6 | |
| DQMSLLQSAWMEILI | 271 | O95718 | |
| TEEEKQLSLTMMAQW | 486 | Q6UWW8 | |
| ETSMIHWTRQIKEML | 246 | Q9P225 | |
| EMILTVQRQWMYLEN | 1441 | Q9P225 | |
| LKETGIANIAWMVIM | 661 | Q9ULF5 | |
| KNTSLVTIFMIWNTM | 116 | Q8NBW4 | |
| DQMSVLQSVWMEVLV | 256 | P11474 | |
| EAVWENMARMCVKTQ | 801 | Q96RY7 | |
| NMATLRMTWEAKVQL | 946 | Q08211 | |
| IPDIFIWMMSNNKRV | 846 | Q9HC10 | |
| RMIWEQNTATIVMVT | 326 | P18433 | |
| MLWEHNSTIIVMLTK | 1726 | P10586 | |
| MLWEHNSTIVVMLTK | 1731 | P23468 | |
| EIYMTWMKNGEEIVQ | 231 | Q95460 | |
| WTLVNDETQAKMARM | 1501 | P42345 | |
| FEAEEEMQIQKSQWM | 336 | Q5VT03 | |
| MAGDTEVWKQMFQEL | 1 | Q9BQQ7 | |
| QMKMENLFVTWQQRS | 2811 | Q5T011 | |
| LMWKPQEQAVTEMIS | 176 | Q9HC62 | |
| TQMTGKELFEMWKII | 221 | Q9H9J2 | |
| FMVWSQIERRKIMEQ | 66 | Q06945 | |
| STEIVSMEEMQWIQF | 651 | Q6YHU6 | |
| EAWIMSRLIKQLTDM | 936 | Q9HCJ0 | |
| VTRLTAEQWVVMMLD | 336 | P0C7P3 | |
| WMNLLNMAKKSVDIV | 136 | Q8N7P1 | |
| ENVMKFMNETTAQWR | 581 | Q8NF91 | |
| ISEVMSWISLMENVI | 6916 | Q8NF91 | |
| NFMKPTQEMNISLVW | 126 | Q8NDZ6 | |
| DIKSIMSMVKSFVQW | 646 | O60502 | |
| VLKMWQFMDQSDIET | 656 | Q9P212 | |
| DMSLQNMKGTERVWV | 1406 | P0DJD1 | |
| MSLITNTIMLIAEWA | 211 | Q8IVM8 | |
| EVQQMWALTEMIRAS | 176 | Q9BSH3 | |
| MVWEQGVNVIAMVTA | 996 | Q15678 | |
| NMVINVMFWKINSTT | 916 | Q7Z443 | |
| AKTQMIMEDWDFLQL | 301 | O14802 | |
| TMVATTWFPKQMVLE | 31 | Q11201 | |
| ALLMNQTVMSKNLFW | 456 | Q9NSC7 | |
| EKMFLWMVTRINQQL | 436 | Q9Y623 | |
| LQEIVEGMKQKMWSI | 361 | P43490 | |
| EGMKQKMWSIENIAF | 366 | P43490 | |
| MWEKSFQRATFMEVQ | 411 | Q9NY99 | |
| LAMTIWILKVMNFTV | 51 | Q96LD1 | |
| MEWIMIKVRVGQETF | 36 | Q8WVI0 | |
| MFNWMVTRINATLET | 436 | P13533 | |
| GEWKVLVVDQLSMRM | 26 | P61764 | |
| KIQSMGVRVMDTNWV | 511 | Q17R89 | |
| SMWAEQKQMELESIL | 81 | P01286 | |
| LTAEKLMEWTSLQNM | 261 | P29508 | |
| LNTTINVMKRMAWEE | 36 | Q8NCY6 | |
| MATATEQWVLVEMVQ | 1 | O15269 | |
| ISNWEVMERLKGMVQ | 46 | Q02040 | |
| FTMWVMLQTLNDEVP | 56 | P54709 | |
| MENSSAWVVEIQMLK | 111 | Q8N1N0 | |
| SEETKMQMFIWNNIF | 411 | O75153 | |
| YEQMLLLMANVKWDV | 791 | Q96JG6 | |
| LLMANVKWDVKEIMS | 796 | Q96JG6 | |
| LWALAMKMAVEEINN | 71 | Q7RTX0 | |
| NFWSMVNLVVMVVVS | 196 | Q9Y3A6 | |
| QVSMDKKTWEQMLLV | 571 | Q6GYQ0 | |
| TQMEDVLKALQMKLW | 206 | Q9NYP9 | |
| RDMYAKVTEIWQEVM | 36 | P08294 | |
| MTIWILKVMNFTIDG | 51 | Q92629 | |
| VWAQVKDSSLMLLQM | 711 | Q6UWL2 | |
| MIKQGLIQKMVAWFE | 91 | Q9BX26 | |
| MQVQMNKGVAVSWET | 131 | A1A519 | |
| QKDMITWILQMFDTV | 971 | Q8IWV7 | |
| KMFLWMVTRINQQLD | 436 | Q9UKX3 | |
| VWVMLMVNSLTEVDI | 166 | Q86V40 | |
| LTAEKLMEWTSLQNM | 261 | P48594 | |
| IQRLLSNMEFMWQFI | 181 | Q8IYU4 | |
| SMEDICQEWTNFIMK | 251 | P49638 | |
| LTMTQLYKVALQWMV | 131 | Q92797 | |
| WKVRAMMIFNTFNLI | 91 | P0C7T8 | |
| ALNFVTMLKMVWISK | 716 | Q9H6S0 | |
| DKRVMLWDVQSGQML | 126 | Q5JTN6 | |
| EMVVFTKEVNEWMAQ | 296 | Q6XPS3 | |
| MMPLKVWELQDLSFQ | 301 | Q9NYU1 | |
| VVWTDAFQMVVMIVG | 181 | Q1EHB4 | |
| FWQMIFQRKVKVIVM | 1046 | P08575 | |
| AMETRGQWAQKLVME | 386 | Q6BDS2 | |
| MLEQLLMNMKVDWAT | 1681 | Q68DK2 | |
| LMNMKVDWATVAVQT | 1686 | Q68DK2 | |
| RVKTTQFTWTEMLIM | 416 | Q13507 | |
| RVLQDWNALKSMIMF | 1331 | O95071 | |
| MAFMTRKLWDLEQQV | 76 | Q5T124 | |
| VKTTQFSWTEMLIMK | 431 | Q9HCX4 | |
| VPMAWKMVVAQQLAS | 706 | P29597 | |
| ENWLSWMFEKLVVVM | 361 | Q96GC9 | |
| FMDLQIMVGRVKDNW | 821 | Q5THJ4 | |
| QLMKDTTLNWKMVDA | 166 | P23919 | |
| SMFQILTQEGWVDVM | 546 | Q8IZF0 | |
| AVEVSEEGAQVMWMK | 366 | Q14324 |